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I dedicate this thesis to all general practitioners and nurses who work hard to 
give children with asthma a high quality of care. 
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The best way to solve a problem and to fight against war is through dialogue 
- Malala Yousafzai 
 
  
ABSTRACT 
Background: Asthma is the most common chronic disease among children in Sweden. Many school-
aged (7-17 years), but also preschool (0-6 years) children with asthma are managed in primary care. 
Evidence-based guidelines have been developed to support the use of current best clinical evidence in 
practice and to ensure high quality care. However, there is a gap between the actual care provided for 
children with asthma and the recommendations stated in the guidelines. 
Aim: To investigate the evidence-based practice for children with asthma in primary care. We wanted 
to evaluate the potential influence of quality of management and effects of learning to apply the 
evidence-based guidelines in routine care. 
Methods: In study I register data regarding dispensed prescriptions was collected. Dispensed 
prescriptions were followed over 24 consecutive months for all children (0-16 years) visiting 14 
primary health care centres (PHCs) and initiated on anti-asthmatic drugs during one year (n=1033). In 
study II physicians and nurses participated in interactive education in these PHCs. 14 PHCs served as 
controls. Register data was collected regarding dispensed prescriptions and recorded diagnosis during 
24 months before and after the intervention. Data was included from all children (0-17 years) (n= 
114 175) listed at the 28 PHCs 2006-2012. Focus group interviews (FGIs) were used in study III to 
evaluate how general practitioners (GPs) approach, learn from and use evidence-based guidelines in 
their decision-making. Qualitative content analysis was used. 22 GPs participated. In study IV quality 
of care was assessed as a composite of quality indicators (CQI). Adherence to quality indicators was 
retrieved by scrutinising electronic health care records at 14 PHCs. By using the multivariate 
regression analysis orthogonal projection to latent structures (OPLS) the relationship between CQI 
and contextual features was evaluated. 
Results:  In study I 54% of the school-aged children had only one prescription dispensed and 50% of 
them were initiated on short-acting beta2-agonist (SABA) as monotherapy. In study II 66% of the 
school-aged children with a recorded diagnosis of asthma were dispensed SABA as well as an anti-
inflammatory anti-asthmatic drug before the intervention. There was no significant statistical 
difference between the intervention and control group at baseline or at follow-up. Approximately one-
fourth of all children who were dispensed anti-asthmatic drugs did not have a recorded diagnosis of 
asthma. In study III three themes were conceptualised in the evaluation of the guidelines: Learning to 
use guidelines by contextualised dialogues; Learning that establishes confidence to provide high 
quality care; Learning by the use of relevant evidence in the decision-making process. In study IV 
more scheduled time for asthma care, lower age-limit for performing spirometry, lower duty-grade for 
GPs and higher activity at the educational seminars were the contextual features with highest 
influence on CQI. 
Conclusion: Most GPs show good adherence to evidence-based guidelines regarding pharmacological 
treatment in children with a recorded diagnosis of asthma. Correct diagnosis of asthma is crucial to 
enable use of evidence-based guidelines. To achieve this, spirometry needs to be performed more 
often. Contextualised dialogue, based on own experience, feedback on own results and easy access to 
short guidelines that were perceived as trustworthy, were important aspects for the use of the 
guidelines. To allocate time, interprofessional collaboration and to create an organisational structure 
with opportunities for engagement in asthma care, are contextual features that have the potential to 
facilitate evidence-based practice for children with asthma.     
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1 INTRODUCTION 
Asthma is today the most common non-communicable disease among children worldwide 
[1]. More than 30% of the preschool children (0-6 years) have had episodes of wheeze, often 
in association with viral respiratory infections [2]. These symptoms are usually resolved by 
school-age (7-17 years) [3]. Still, one study has shown a prevalence of 7.4% physician-
diagnosed asthma among Swedish 7-8 years old children [4]. Another Swedish study has 
shown a prevalence of 9.5 % physician-diagnosed asthma among adolescents (16-20 years) 
[5]. In school-aged children with perennial allergy and asthma the disease should be 
considered as chronic [6-8]. Sensitisation to airborne allergens occurs in 60-80% of school-
aged children with asthma [8, 9]. Even if they get symptoms mainly at exercise, it is 
important to have the knowledge that these children should be treated continuously with anti-
inflammatory anti-asthmatic drugs [10]. 
Unlike many other chronic diseases asthma often starts early in life and persists into 
adulthood [11]. Asthma is one of the most common diseases managed in Swedish primary 
care [12]. It is also a disease that can have a great impact on a patient´s quality of life. 
Swedish health care differs from health care in many other countries since the general 
practitioners (GPs) do not have a gatekeeper function. Patients are thus often free to seek care 
also from other providers [13, 14]. Nevertheless, the health care system is based on the 
presumption that the patients should have all relevant basal investigations performed and 
evaluated in primary care before referral to secondary care. 
The formal requirements to qualify as a GP in Sweden, are equivalent regard to years in 
training and acquired competence as to the requirements for any specialist in secondary care 
[15]. Consequently, there are high expectations on GPs to investigate and manage a wide 
spectrum of diseases in primary care. However, while evidence-based guidelines are designed 
to guide the treatment of separate diagnoses, many patients in primary care have multiple 
health problems which makes implementation of guidelines in primary care a complex task 
[16].   
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2 BACKGROUND 
2.1 DEFINITION OF ASTHMA AND ASTHMA CRITERIA 
Asthma is defined by airway inflammation and bronchial hyperresponsiveness causing 
completely or partly reversible airway obstruction [6]. It is a heterogeneous disease with 
variable symptoms such as cough, wheezing, shortness of breath and/or reduced physical 
activity [6]. Diagnosing asthma in preschool children is difficult, especially in children 
younger than three years of age. The following criteria for asthma have been suggested by the 
Global initiative for asthma (GINA) in children younger than three years of age: 
 Symptoms (wheeze, heavy breathing) for >10 days during viral respiratory 
infections 
 More than three episodes per year, or severe episodes and/or night worsening 
 Cough, wheeze or shortness of breath/heavy breathing between episodes of viral 
respiratory infections 
 Symptoms (wheeze, heavy breathing) for <10 days during viral respiratory 
infections and atopy or family history of asthma. 
One or more of the criteria should be fulfilled for the diagnosis of asthma in this age-group. 
In children three years and older, wheeze or heavy breathing during a viral respiratory 
infection should always be considered as a potential diagnosis of asthma with the need for 
follow-up [6]. 
In children older than five years the GINA guidelines have suggested the following criteria 
for the diagnosis of asthma: 
 A history of respiratory symptoms such as wheeze, shortness of breath, chest 
tightness and cough that vary in intensity and over time and 
 Variable expiratory airflow limitation 
In this age-group it is usually possible to measure the airflow limitation by lung function 
tests, preferably spirometry. 
2.2 EVIDENCE-BASED GUIDELINES AND QUALITY OF CARE 
Rapid advances in medicine set high requirements on physicians to keep a high quality of 
care. Management of childhood asthma is no exception. The concept of evidence-based 
medicine (EBM) was developed in the 1990s and could be described as “the conscientious, 
explicit and judicious use of current best evidence in making decisions of the care of 
individual patients” [17].  However, to find the best evidence for the specific patient is a 
process in several steps [18]. The first step is to define a clinical question. The next step is to 
search for information in a structured way in available databases. The third step is to evaluate 
the data obtained. Randomised controlled trials (RCT) that evaluate different treatments in 
two equivalent groups are considered to have the highest level of evidence. Yet, patients 
included in these studies are usually within a certain age-span and have only one specific 
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disease. The data obtained may therefore not be applicable for children or for old patients 
with multiple diseases, which are common patient groups in primary care. The fourth and last 
step is therefore to evaluate if the evidence is usable in a specific health care context. Further, 
if it is so, to apply the evidence in this local routine practice.  
To use the process for EBM in daily routine practice is not possible. However, evidence-
based guidelines have been developed to support the use of the best clinical evidence in 
practice. There are international as well as national and regional guidelines [6, 7, 10]. The 
purpose of the national and regional guidelines is to adapt the international guidelines to the 
Swedish health care context in order to facilitate adherence. These guidelines are therefore 
developed in collaboration with specialists in the area, for example paediatric allergologists, 
GPs and asthma nurses. Still, the guidelines do not consider the local context at each primary 
health care centre (PHC) which in turn will affect the final evidence-based practice (EBP). 
Figure 1 shows how EBM is mediated via evidence-based guidelines to EBP at the PHCs. 
 
Figure 1. Flowchart of how evidence-based medicine is mediated via evidence-based guidelines to evidence-
based practice at the primary health care centres. 
 
The local context has high influence on the decision-making process. Decision-making is a 
core fundament for evidence-based clinical practice in primary care. To make correct 
decisions that are adapted to the individual patient as well as to the health care system is a 
prerequisite for quality of care. Decision-making is complex and there are several theories on 
the process of decision-making and how to optimise the process depending on the context. 
Norman et al. [19] have in a review on clinical reasoning or decision-making concluded that 
there are three major approaches to solve problems in clinical routine practice. In the first 
approach, hypo-deductive reasoning the clinician has gathered extensive amounts of 
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knowledge. In each patient encounter the physician rules out the hypotheses that will not fit 
in and reach a decision. In the second approach, schema induction, decision-making is built 
on schemas for example decision trees that begin with clinical presentations and end with 
specific diagnoses. In the third approach, pattern recognition by earlier experience is central. 
None of the approaches fits all clinical situations and there is no gold standard for decision-
making in clinical routine practice. 
During the past years the Dual Process Theory has become a dominant model for 
understanding the complex process underlying human decision-making [20-22]. According to 
this theory the decision-making process is a balance between a fast intuitive system built on 
pattern recognition and a slower analytic system built on theoretical analysis of data. Either 
system may override the other, and there is a tendency in the system to strive for the least 
cognitive effort in the decision-making process.  
Evidence-based guidelines are developed to increase quality of care and to provide evidence- 
based safe and effective use of diagnostic and therapeutic technologies [23, 24]. Quality of 
care can be defined as ” the extent to which health services increase the likelihood of desired 
health outcomes and how close they (the health services) adhere to professional knowledge” 
[18]. Quality of health care can be divided in three major components: structural aspects of 
care such as credentials of GPs,  processes of care that indicate what was done and outcomes 
of care that reflect the short or long-term results of services. It may also include the patient 
satisfaction with care [18]. 
There are different reasons for why and how quality should be assessed in health care. It 
could be a way for clinicians to obtain objective information about their practices. Further, it 
could be a way for patients to know about quality of care available [25]. One way to assess 
quality in a practice is as a measurement of results over time, i.e. to measure quality 
enhancement. This can either be performed as measurement of own results or as a 
comparison of other care-givers. Activities to stimulate enhancement of quality are performed 
between the measurements. 
In order to assess quality, quality indicators have been developed. The original definition of a 
health care quality indicator was proposed by Lawrence and Olesen in 1997 as “ a 
measurable element of practice performance for which there is evidence or consensus that it 
can be used to assess the quality, and hence change in the quality, of care provided” [26]. 
Recommendations about diagnosis and treatment in a given guideline can be synthesised into 
algorithms which can be used as quality indicators. By determining how well a health care 
provider meets these quality indicators can be a way to measure quality of care [23]. Quality 
indicators are thus important tools to improve quality of care [27]. They can be used from 
different perspectives. In the regional guidelines for the county council of Stockholm the 
following perspectives have been suggested [7]: 
 The care-giver can use the quality indicators to develop an optimal quality of care  
 The health care principals can use the quality indicators as an aid when deciding how 
the resources should be used and distributed in primary and secondary care. 
 The patient can use the quality indicators to ensure a good quality of care 
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For a global assessment of quality it is desirable to combine quality indicators to a composite 
– a composite quality indicator (CQI) [28]. Composite scores also have the advantage that 
much smaller samples or records are required to give reliable scores than are required for 
single quality indicators [29]. There are several methods described how to generate a 
composite score for a group of quality indicators depending on what is to be compared [27, 
28]. However, there is no gold standard regarding method. 
2.3 EVIDENCE-BASED MANAGEMENT OF ASTHMA  AND LEVEL OF CARE 
There is no single test to diagnose asthma. The diagnosis of asthma is based on the clinical 
history and lung function testing. According to evidence-based guidelines, spirometry is the 
lung function test that should be used in diagnostics of, as well as in follow-up of asthma [6, 
7, 10]. However, spirometry is usually not possible to perform in preschool children. The 
diagnosis of asthma in this age-group is often based on clinical history and the response of 
the child to pharmacological treatment. 
Management of asthma includes awareness of, and as far as possible, elimination of 
worsening factors. Active as well as passive smoking should be avoided in all children [30].  
Testing for allergy should be offered for all school-aged children with asthma and on wide 
indications for younger children [10]. School-aged children with allergic asthma often have a 
chronic inflammation in the airways due to regular exposure to animal dander in school dust 
[31, 32]. 
Pharmacotherapy is the cornerstone in the treatment of asthma [6, 7, 10, 33]. Most of the 
school-aged children with asthma need regular treatment with anti-inflammatory anti-
asthmatic drugs. The purpose with the maintenance treatment is that the children should be 
free from symptoms in their daily life and have a good asthma control [6, 7, 10]. 
Most of the anti-asthmatic drugs are administered by inhalation. Inhalation therapy can be 
administered by pressurised metered dose inhalers (pMDIs) with or without spacers, dry 
powder inhalers (DPIs) or by nebulisers. Consequently, there are many different types of 
devices. To demonstrate and to follow up the inhalation technique for the prescribed device is 
therefore necessary [6, 7, 33]. 
School-aged children with mild to moderate asthma could preferably be treated in primary 
care [7, 34]. In preschool children, asthma that only appears in connection with respiratory 
infections is usually managed in primary care [7]. Children with asthma that do not respond 
to the recommended basic treatment or need regular treatment with anti-asthmatic drugs 
should be referred to a paediatrican [7, 10]. This is especially important in children aged < 2 
years since the evidence regarding treatment of asthma in this age-group is limited. The 
recommendations for treatment of asthma in this age-group are mainly based on 
extrapolations of studies on older children and expert opinions [34]. The different levels of 
treatment of asthma in the two age-groups and recommended level of care are shown in 
tables 1 and 2. 
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Table 1. Swedish recommendations for treatment and level of care in children ≤ 6 years 
Level of 
treatment 
Asthma symptom Recommended treatment 
1 Asthma symptoms only in 
association with viral 
respiratory infections 
Mild symptoms: SABA
1
 (preferably inhaled 
with spacer) as monotherapy 
Moderate symptoms: Montelukast 4 mg/day 
or ICS
2
 in a predefined dosing regimen in 10 
days. SABA
1
 as needed 
2 Continuous symptoms or 
severe symptoms in 
association with infections 
Regular treatment with ICS
2
 in low to 
moderate dose (100-200 microg/day). 
Montelukast 4 mg/day is an alternative in 
mild symptoms. SABA
1
 as needed 
3 Uncontrolled symptoms 
despite treatment at level 2 
ICS
2
 in low to moderate dose+ montelukast 4 
mg/day. LABA
3
 can be added from age 4. 
SABA
1
 as needed 
4 Uncontrolled symptoms 
despite treatment at level 3 
ICS
2
 in high dose (>200 microg/day) + 
montelukast 4 mg/day. LABA
3
 can be added 
from age 4. SABA
1
 as needed. 
1
SABA denotes short-acting beta2-agonists 
 2
ICS denotes inhaled corticosteroids, in this table only fluticasone 
3
LABA denotes long-acting beta2-agonists. 
The gray-shaded area indicates that primary care is recommended level of care. This table is based on the 
recommendations of the Swedish Medical Products Agency [34]. 
 
Table 2. Recommendations for treatment and level of care in children > 6 years 
Level of 
treatment 
Asthma symptom Recommended treatment 
1 Mild/intermittent asthma 
symptoms 
SABA
1
 as monotherapy 
2 Recurrent effort-induced 
symptoms/need of SABA > 2 
times/week 
ICS
2
 in low to moderate dose ( 200-400 
microg/day). Montelukast 5-10 mg/day is an 
alternative in mild symptoms. SABA
1
 as 
needed 
3 Uncontrolled symptoms 
despite treatment at level 2 
ICS
2
 in low to moderate dose ( 200-400 
microg/day) + montelukast 5-10 mg/day 
and/or LABA
3
 (or as fixed combination). 
SABA
1
 as needed 
4 Uncontrolled symptoms 
despite treatment at level 3 
As in step 3 but with ICS
2
 in high dose (>400 
microg/day) 
5 Uncontrolled symptoms 
despite treatment at level 4 
Highly specialised treaments such as 
omalizumab, Airsonett, theophylline, 
azitromycine, oral steroids. 
1
SABA denotes short-acting beta2-agonists 
2
ICS denotes inhaled corticosteroids, in this table budesonide and 
fluticasone 
3
LABA denotes long-acting beta2-agonists. 
The gray-shaded area indicates that primary care is recommended level of care. The table is based on the 
recommendations of the Swedish Medical Products Agency [34]. 
The concept management has several, partly dependent interpretations [35]. In health care it 
could be interpreted as how a disease should be handled (management of asthma) or as the 
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head and leadership of an organisation (the management for a PHC). These two 
interpretations are partly dependent on each other. Thus, the resulting quality of the 
management of a disease might be more or less dependent on the quality of the management 
of the organisation where the disease is handled.   
2.4 EFFECTS OF LEARNING AND ORGANISATION OF CARE ON EVIDENCE-
BASED PRACTICE 
Adherence to evidence-based guidelines is known to be low, in routine practice of childhood 
asthma as well as in many other areas [36-42]. Core prerequisites to perform evidence-based 
practice require adequate medical knowledge and skills. Transfer of knowledge is 
traditionally associated with a one-way communication from a more knowledgeable person to 
a less knowledgeable one. This knowledge can be transmitted from a teacher to a student or 
from textbooks to a physician. However, to perform evidence-based practice knowledge is 
insufficient. A second step is needed: to achieve competence to apply the knowledge in 
practice. This step includes an adaption to the specific situation and the experiences of the 
receiver. The receiver can be seen as an expert on possibilities and limitations in the local 
context. Learning can thus be defined as “a process that takes place through the active 
behaviour of the student: it is what he does that he learns, not what the teacher does” [43]. 
The process of learning includes acquiring information, applying it to the context and having 
time for reflection [44]. If this process is fulfilled it results in deep own knowledge and may 
change behaviour [44]. 
It has been shown that written educational material alone is not sufficient to provoke change 
of the behaviour of health care professionals [36]. Furthermore, educational meetings based 
on lectures are unlikely to change professional practice [45]. However educational research 
indicates that methods including interactive learning and active participation have the 
potential to increase knowledge and skills and to change behaviour [46]. Case-method 
learning is based on decision-making [47]. A case in case-method learning includes 
analytical, conceptual and presentation dimensions [47]. These dimensions could be divided 
into three levels of difficulties. Cases in clinical practice are all complex in the analytical and 
conceptual dimensions. There is no obvious decision and the discussion of the cases requires 
that the participants have knowledge and skills not supplied in the case. This model has 
previously been shown to support evidence-based practice in primary care [48, 49].   
The purpose of guidelines is to evoke changes in management towards evidence-based 
practice in primary care and thus change of the behaviour of health care professionals. The 
implementation strategy of guidelines is therefore crucial. 
There are many ways to communicate evidence-based guidelines. To use internet-based 
guidelines is becoming increasingly common. This facilitates the process to get quick access 
to a large amount of updated knowledge. Yet, the vast amount of information available could 
also be a barrier in sorting out the important information. Furthermore, the limited 
possibilities for interactivity offered in the internet-based guidelines may impair the learning 
process. Figure 2 shows how information could be handled in the learning process by GPs in 
primary care. There is thus an important difference between surface knowledge, which could 
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be expressed as “knowledge for the moment” and deep knowledge when the information is 
processed and reflected. 
 
Figure 2. Cognitive levels of learning applicable in the learning process for GPs in clinical practice. This figure 
is inspired by John Biggs and Catherine Tang  [44].  
 
The management, organisation and structure of health care are important if evidence-based 
care should be obtained. An effective basic service has indeed been associated with greater 
patient satisfaction than easily accessible secondary care [50]. However, a high workload for 
GPs was associated with a lower adherence to evidence-based guidelines [51]. Financial 
incentives lead to a feeling of lower professional autonomy, which in turn made physicians 
rate a lower quality of care [52]. Further, leadership quality has been considered a necessary 
factor in reducing work pressure and protecting the organisation of the health care unit, for 
example a PHC [52]. 
Yet, in order to evaluate adherence to evidence-based guidelines it is important to evaluate 
the adequate study population. RCTs are considered as the gold standard when evaluating 
evidence-based medicine. They are designed to test whether an intervention works under 
optimal conditions. However, in order to evaluate what affects adherence to evidence-based 
guidelines, the studies must be pragmatic. Pragmatic trials are designed to evaluate the 
effectiveness of interventions in real-life routine practice [53-55]. Further, to be able to 
improve adherence it is necessary to understand facilitating and hindering aspects in the 
decision-making process and to evaluate which contextual factors that are most important in 
high quality care.      
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3 AIMS 
The overall aim of the thesis was to investigate the evidence-based practice for children with 
asthma in primary care. We wanted to evaluate the potential influence of quality of 
management and effects of learning to apply the evidence-based guidelines in routine care. 
The specific aims were: 
 To explore the pattern of dispensed anti-asthmatic drugs to children in relation to the 
evidence-based guidelines 
 To investigate the effect of an educational intervention on adherence to evidence-
based guidelines regarding diagnosis and dispensed anti-asthmatic drugs to children 
treated in primary care. 
 To explore how general practitioners approach, learn from and use evidence-based 
guidelines in their day-to-day decision-making process in the primary care context. 
 To evaluate the influence of contextual features on the PHCs´ adherence to the quality 
indicators stated in the evidence-based guidelines for treatment of asthma in children. 
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4 ETHICAL CONSIDERATIONS 
All investigations conform to the principles outlined in the “Declaration of Helsinki; 1964”. 
The Regional Ethical Review Board in Stockholm, Sweden approved all included studies. 
Register numbers for the permits are: Study I: 2007/1497-31/4, study II: 2013/1126-31/5, 
study III: 2007/1497-31/4 and 2011/1071-32, study IV: 2007/1497-31/4. 
The managements of each of the 14 PHCs actively participating in all four studies were 
informed about the studies and gave their written consent to participate. The 14 additional 
PHCs forming the control group in study II, were not informed about the study.  The reason 
for this was that we only retrieved anonymised register data from these PHCs and our study 
did not in any way affect the clinical practice for the physicians or the care of the children. 
In study III all GPs and residents in family medicine working at the included 14 PHCs 
received written information about the study. The GPs and residents that participated had thus 
made an active choice to participate in the focus group interviews. Each individual participant  
gave their written consent and the transcribed data was coded. We performed the interviews 
either during day-time or in the evening depending on what was most suitable for the 
physicians and their clinical practice. 
Study IV included studies of electronic health care records. Studies of health care records can 
be an ethical dilemma since the physicians may perceive that their professional skills are 
questioned. However, it was the behaviour of the physicians we studied and the electronic 
health care records were only tools for this. For practical reasons it was not possible to 
anonymise the health care records for the research nurses that scrutinised them. However, the 
two nurses had no other connection to the study and the collected data was anonymised to the 
rest of the research group. We did not retrieve consent from the children concerned or their 
parents. Since the purpose of the study was to follow up the quality of care there was no legal 
requirement for consent from them. Further, all data was presented at group levels which 
eliminated the risk for identification of an individual physician or patient. Finally, to obtain 
objective data it is important to get a representative material. Excluding some physicians or 
patients from the PHCs would have decreased the chance of objective data and thus 
decreased the validity of the study. 
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5 METHODS 
5.1 OVERVIEW OF THE THESIS 
A summary of the studies in the thesis and how they relate to each other is shown in table 3. 
Table 3. Overview of the four included studies 
 Study I Study II Study III Study IV 
Design 
 
Retrospective 
observational 
study  
Controlled 
educational 
intervention 
study 
Qualitative 
interview study  
Cross-sectional 
study 
Procedures 
studied 
Dispensed anti-
asthmatic drugs 
at baseline 
Dispensed anti-
asthmatic drugs 
before and after 
intervention 
Use of 
evidence-based 
guidelines 
Influence of 
contextual 
features on 
quality of care 
Material Physicians and 
children at14 
PHCs
1 
Physicians and 
children at 14 
PHCs
1
 + 14 
PHCs
2 
22 GPs
3
 
selected from 14 
PHCs
1 
Physicians, 
nurses and 
children at14 
PHCs
1 
Number of 
children 
included 
1033 
(included by 
registerdata) 
114 175 
(included by 
registerdata) 
- 559 
(included by 
data from health 
care records) 
Study period 2005-2009 2006-2012 2011 2008-2012 
1
Primary health care centres that received educational intervention. 
2
Primary health care centres that served as 
matched controls. 
3
General practitioners 
5.2 STUDY MATERIAL 
The physicians, mainly general practitioners (GPs), and nurses were studied at group level. 
Electronic health care records of children were studied. The health care records of the 
children were included (study I, II and IV) with the purpose to study the physicians´ clinical 
practice. 
5.2.1 Primary health care centres (I-IV) 
GPs and nurses from all primary health care centres (PHCs) in the northwestern part of 
Stockholm, Sweden were invited to a seminar in paediatric asthma. In total, GPs and nurses 
from 49 PHCs were invited and participants representing 20 of these PHCs attended the 
seminar. Of these 20 PHCs, 14 agreed to participate in a survey of contextual features and 
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documentation of quality indicators as a measure of quality of care in the electronic health 
care records (study II and IV). GPs and nurses in these 14 PHCs were also interested in 
further interactive education in pediatric asthma (study II and IV). These 14 PHCs that thus 
had active interest in pediatric asthma were included in all four studies. 
In study II, 28 PHCs were included. The added 14 PHCs in this study were retrieved from 
the regional census register of Stockholm County Council which has complete information on 
listing status for all inhabitants in the region. These 14 PHCs were individually matched by; 
number of listed people, proportion of the listed population who were children aged 0-17 
years, if the PHCs were run by public or private actors, and care need index (CNI), a social 
deprivation index based on socio-economic factors [56] (table 4). CNI is described in detail in 
section 5.3.3. 
Table 4. Characteristics of the primary health care centres (PHCs) included in the thesis. 
Characteristic Intervention group Control group 
Number of PHCs 14 14 
Type of ownership 
(public/private) 
 
9/5 
 
8/6 
Number of listed people
1
 11751 (5552-20339) 9670 (5508-19984) 
Number of listed children, 0-17 years
1 2336 (906-4233) 1882 (1145-3971) 
Proportion of listed children, 0-17 years
1 0.20 (0.14-0.25) 0.22 (0.15-0.27) 
Care need index (CNI)
1 1.09 (0.74-1.89) 0.89 (0.58-1.67) 
1
Data presented as median (total range). CNI is described in detail in section 5.3.3 
The data presented is from 2012.  
 
5.2.2 Physicians (I-IV) and nurses (IV) 
In study I and II all physicians working at the PHCs during the study period were included. 
We also included physicians in secondary care when we compared dispensed anti-asthmatic 
drugs prescribed from PHCs and secondary care respectively. 
In study III all GPs and residents in family medicine from 14 PHCs (in total 132 physicians 
at this specific point of time in 2011) were invited to participate in the focus-group 
interviews. In total 22 physicians (16 GPs and six residents in family medicine) representing 
seven PHCs agreed to participate. The participating physicians had a median of seven years 
of experience in primary care (interquartile range 3-14 years) and 16 of them were women. 
In study IV the documentation of the quality indicators in the electronic health care records 
could have been performed by any of the physicians working at the PHCs during the study 
period. However, the contextual data gathered concerned mainly GPs, residents in family 
medicine and nurses working at the PHCs as described in section 5.3.5. 
5.2.3 Children (I, II, IV) 
In study I and II the data of the children´s asthma medication was retrieved from registers. 
In study I, all children aged 0-16 years with at least one dispensed prescription of anti-
asthmatic drugs between July 2006 and June 2007, following a one-year period without any 
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prescribed anti-asthmatic drugs were included. The children were followed for 24 
consecutive months regarding dispensed anti-asthmatic drugs. All children had at least one of 
the prescriptions issued from one of the included 14 PHCs. In total data from 1033 children 
was included in this study. 
In study II all children aged 0-17 years, i.e. all people born 1989-2012, listed in any of the 
included 28 PHCs at any point in time between 2006 and 2012 were included. In total data 
from 114 175 children was included.  
In study IV electronic health care records from 20 children with a recorded diagnosis of 
asthma (ICD-10 code J45) and 20 children with a recorded diagnosis of either obstructive 
bronchitis (ICD-code J22) or cough (ICD-code R05) were included from each of the 14 
included PHCs. The children should be between six months and sixteen years old and have 
had at least one visit at one of the included PHCs with the specified diagnosis during any time 
in the electronic health care records. The children with a recorded diagnosis of asthma should 
in addition have had at least one visit with this diagnosis during the year the electronic health 
care records were scrutinised. In total, health care records from 279 children with asthma and 
280 children with obstructive bronchitis or cough were included. Data from these children 
were also included in study II in order to identify specific needs in the educational seminars. 
5.3 PROCEDURES 
5.3.1 Educational seminars (II, IV) 
The 14 PHCs in the intervention group were offered seminars based on case-method learning 
at their own PHC. Since decision-making is crucial in clinical practice in primary care, case-
method learning was suitable as an educational method. However, for practical reasons it was 
not possible for the physicians and nurses to prepare the cases in advance. We therefore used 
a simplified model of case-method learning and presented the cases and finished the 
discussions at each seminar. The cases were based on the two main questions: What? and  
How? These questions were usually followed up by: Who? When? and Why? 
A good management of asthma in children is best obtained by team-based interprofessional 
care [57-60]. Physicians and asthma nurses together were invited to the seminars. Three 
seminars of 1-1½ hours were held at each PHC within 5-10 months. Physicians were 
represented at all the seminars. Median attendance rate for physicians participating in all three 
seminars was 66 % (interquartile range 52-78 %). Nurses were represented in 80 % of the 
seminars. In 57 % of the PHCs, nurses were represented in all three seminars. A specialist in 
paediatric allergy (the author) and a nurse with special education in allergy led the seminars. 
The first seminar was based on the same case for all the PHCs (see appendix 1 for a summary 
of the case). 
 The case in the first seminar was focused on patient education. 
 The case in the second seminar was focused on areas of paediatric asthma depending 
on specific needs and desires for each PHC. The specific needs were identified by 
surveys of the electronic health care records for documentation of the prioritised 
quality indicators stated in table 6. The cases focused on pharmacological treatment of 
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asthma and inhalation technique, the importance of team-based interprofessional care 
or diagnostic difficulties. Some PHCs discussed more than one topic. 
 The third seminar aimed to follow up and discuss the specific areas with need for 
improvement identified for each PHC. The purpose was to discuss how to implement 
changes in the context of the PHC. 
  
To manage children with asthma is a challenge for interprofessional collaboration. The focus 
of our seminars was thus to present cases that stimulated interactive discussion between the 
participants. To further stimulate engagement and interactivity the discussions started with 
small group discussion with two to three people and continued in the whole group. 
Engagement and interactivity at the seminars were scored in three levels, based on structured 
field notes. These levels are shown in table 5. 
The assessed level at the seminars was used in study IV as a proxy for interactive culture at 
the PHC.  
Table 5. Level of engagement at the seminars.    
Level of 
engagement 
Definition 
Low (1) The participants are listening to the seminar leader but only a minority of 
the participants talk to the seminar leader and there is no interaction 
between the participants. 
Medium (2) The participants interact and discuss with the seminar leader but not with 
each other. 
High (3) Interactivity and discussion between the participants. The seminar leader 
supports the discussion. 
 
5.3.2 Quality assessment (I, II, IV) 
Adherence to evidence-based guidelines was assessed as fulfilment of the quality indicators 
stated in table 6 [23, 26, 61]. The ones with an assigned value of 1 have been stated by the 
Swedish National Board of Health and Welfare as prioritised to ensure a high quality of care 
[62]. The ones with an assigned value of 0.5 were based on consensus and local practice 
guidelines and considered important to add in order to obtain a high quality of asthma care in 
children [7]. 
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Table 6. Quality indicators according to the evidence-based guidelines 
Quality indicator
 
Value  Age-group to be considered 
Diagnostic criteria for asthma fulfilled 1 All ages 
Documentation in patient history:    
History of allergy 0.5 All ages 
Heredity of asthma and allergy 0.5 All ages 
Exposure to furred pets 0.5 All ages 
Exposure to tobacco 1 All ages 
Diagnostics and patient support:    
PEF
1
 performed 0.5 ≥ 5 years 
Spirometry performed 1 ≥ 9 years 
Inhalation technique 
demonstrated 
1 All ages 
Patient education offered 1 All ages 
Pharmacological 
treatment/Consultation 
  
Treatment with inhaled 
corticosteroids or 
paediatrician consulted 
1 All ages 
1
PEF denotes peak expiratory flow.   
 
5.3.3 Quality assessment of pharmacological treatment (I, II) 
Registers were used to investigate the patterns of dispensed anti-asthmatic drugs (study I and 
II) and to investigate their relation to the diagnosis of asthma (study II). Registers were also 
used to retrieve socio-demographic factors (study II).  
In the first part of study II the main purpose was to compare dispensed anti-asthmatic drugs 
prescribed in the intervention and control group by primary care only, before and after the 
intervention. Data was collected regarding dispensed anti-asthmatic drugs to children with a 
recorded diagnosis of asthma. However, we also collected data regarding dispensed drugs 
prescribed by secondary care only, during the same periods of time. Secondary care included 
all specialties but the dispensed anti-asthmatic drugs were in more than 95 % prescribed by 
paediatric out-patient clinics. The children included were all listed at the 28 PHCs in the 
study. When comparing primary and secondary care the primary care intervention and control 
group were merged. In the second part of study II data was collected regarding dispensed 
anti-asthmatic drugs prescribed by primary care to all children that were listed at the 28 
PHCs. The proportion of these children that had a recorded diagnosis of asthma was then 
calculated. In both parts of study II data collection was performed before and after the 
educational intervention. The children were split in two age-groups: ≤ 6 years (preschool) and 
> 6 years (school-age) according to the guidelines regarding pharmacological treatment 
(study I and II) [6, 7, 10]. 
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The following anti-asthmatic drugs were included in study I and II: 
1. Short-acting beta2-agonists (SABA): salbutamol (ATC-code R03AC02, R03CC02), 
terbutaline (ATC-code R03AC03, R03CC03) 
2. Long-acting beta2-agonists (LABA):  salmeterol (ATC-code R03AC12), formoterol (ATC-
code R03AC13) 
3. Inhaled corticosteroids (ICS):  beclometasone (ATC-code R03BA01), budesonide (ATC-
code R03BA02), fluticasone (ATC-code R03BA05) 
4. Fixed combinations: salmeterol+ICS (ATC-code R03AK06), formoterol+ICS ( ATC-code 
R03AK07) 
5. Leukotriene receptor antagonist: montelukast ( ATC-code R03DC03) 
The oral solutions of salbutamol (R03CC02) and terbutaline (R03CC03) were not included in 
study I. All the anti-asthmatic drugs were classified according to the Anatomical 
Therapeutical Chemical system [63]. Data was collected from the following registers: 
 Data on dispensed anti-asthmatic drugs including care-giver and prescription date was 
collected from the Swedish Prescribed Drug register. This register was established in 
2005 and contains data on dispensed prescription drugs in ambulatory care for the 
entire Swedish population (99.8% population coverage) [64]. 
 Data on recorded diagnoses was collected from the regional data warehouse on health 
care consumption, GVR/VAL, held by the Stockholm County Council. All 
appointments and diagnoses are reported and stored in GVR/VAL [65]. 
 Data on listed people was collected from the regional census register This is an 
electronic service in which the PHCs register the patients that they have listed. The 
PHCs check and update the register regularly since the listing status at the PHCs is a 
cornerstone in the financial compensation for the PHCs. 
 Data on socio-demographic characteristics was based on the care need index (CNI) 
for the geographic area where the PHC was situated. CNI is based on the following 
sociodemographic factors: elderly people (> age 64) living alone, children under age 
5, unemployed people ( aged 16-64 years), single parents with children aged 17 years 
and younger, high mobility (people ≥ 1 year who have moved to the area during the 
past year and foreign born people from southern and eastern Europe, Asia, Africa and 
South America. Average CNI for Stockholm as well as for the rest of Sweden is 1.0. 
A CNI >1.0 indicates that people living in the area have higher rates of psychiatric 
hospital admissions and cardiovascular risk factors than average. 
 
An overview for the registers used in the different studies is shown in table 7 
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Table 7. An overview of the registers and the studies they were included in 
Register Study I Study II Study III Study IV 
The Swedish 
Prescribed 
Drug register 
 
X X - - 
The GVR/VAL 
 
- X - - 
The regional 
census register 
 
- X - X 
The CNI - X - X 
X= included,  - = not included 
 
5.3.4 Approach to, learning from and use of evidence-based guidelines 
explored by focus group interviews (III) 
Qualitative research aims to interpret the meaning of the collected data which usually 
consists of observations, interviews or written documents [66]. The interpretation is 
performed by analysing the content. Focus group interviews (FGIs) focus on a specific 
subject, in this study the use of evidence-based guidelines in decision-making. A structured 
interview guide was prepared in advance. The interview guide consisted of an opening 
question, three core questions and finally a closing question. Probe questions or questions for 
clarification were prepared to be used if needed [67, 68]. The interview guide is shown in 
appendix 2. The author conducted the interviews and a behavioral scientist acted as an 
observer in order not to miss any data.  Between three and eight physicians participated in 
each FGI. By performing group interviews, there were discussions between the participants 
as well as with the interviewer and thus a rich amount of data was obtained [69]. We 
performed in total four FGIs. In the fourth FGI no new data was obtained and thus no more 
interviews were performed.  
The interviews were recorded and transcribed verbatim by the author. Qualitative content 
analysis was then performed by using the methods described by Graneheim and Lundman 
and by Krueger [70, 71]. First, meaning units in the transcripts were identified and sorted by 
content and meaning [71]. Second, meaning units were condensed and labelled with codes 
while still preserving the core [70]. Codes that belonged together were grouped to form 
categories [70]. In the last step, the content in the categories was interpreted and themes were 
created [70]. In interpreting and discussing the themes the Dual Process Theory was applied 
[20-22]. The Dual Process Theory was applied since decision-making was central in this 
study. 
5.3.5 Evaluation of the influence of contextual features on quality of care (IV) 
Quality of care for children with asthma at each PHC was defined as a composite quality 
indicator (CQI) of all the quality indicators shown in table 6 [28]. The CQI was calculated by 
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taking the proportion of documentation of each quality indicator and then multiplying it with 
its assigned value. The obtained numbers were then summarised. The possible range for each 
PHC was thus 0-8 points. 
The influence of the separate contextual features on CQI was then assessed. 
Predefined checklists, personal contacts with the managements of the PHCs, questionnaires 
and levels of engagement and interactivity at the educational intervention were used to collect 
data regarding contextual features at the PHCs. Registers were used for socio-demographic 
characteristics (table 7). 
The predefined checklist that was filled in by each of the participating PHCs is shown in 
appendix 3. The checklists were filled in one month after the seminars were completed. At 
this point in time the author and the nurse who led the seminars also contacted the 
management for the PHCs by e-mail or telephone. This was done in order to collect data 
regarding mean duty-grade of the physicians (GPs and residents in family medicine), 
vacancies and change of medical software during the period of the seminars. Further, 
questionnaires were distributed to the GPs and residents in family medicine. The 
questionnaires dealt with the physicians´ perceptions of their adherence to the evidence-based 
guidelines regarding paediatric asthma including barriers and facilitators. However, very few 
questionnaires were completely filled in. The results could therefore not be interpreted in a 
reliable way, why the response rate instead was used as a measure of engagement. 
The assessed level of engagement at the seminars that was used as a proxy for interactive 
culture is shown in table 5. 
5.4 STATISTICS 
For all comparisons a two-tailed probability of ≤ 0.05 was considered significant. 
In paper I standard descriptive statistics (number and proportions) were used to describe the 
study cohort and the utilisation pattern of the drugs. The obtained data was processed in 
Microsoft Excel v.2003, SYSTAT II v.2004 (SYSTAT software, Richmond, CA, USA) and  
SAS v. 9, 1.3 SP 3, 2004 (SAS Institute, Cary, NC, USA). 
In paper II standard descriptive statistics (number, proportions, median and total range) were 
used to describe the study cohort. Pearson Chi-square test for categorical data with two 
variables was used to compare the intervention and control group in primary care regarding: 
patterns of dispensed anti-asthmatic drugs, proportion of children dispensed anti-asthmatic 
drugs that had a recorded diagnosis of asthma and prevalence of asthma. This test was also 
used to compare the patterns of dispensed drugs in primary and secondary care. 
In paper IV median and interquartile ranges or proportions were calculated for all variables. 
Chi-square test and Fisher´s exact test were used for comparison of categorically variables of 
the groups of PHCs with low versus high CQI. Mann-Whitney U tests (for non-normally 
distributed data) and unpaired t-tests (for normally distributed data) were used for comparison 
of continuous variables between the groups of PHCs. 
The statistical software IBM, SPSS version 22 (IBM, Chicago, IL, USA) was used for these 
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analyses in paper II and IV. 
In addition in paper IV, a multivariate regression analysis was performed by Orthogonal 
Projection to Latent Structures regression (OPLS) using the non-linear iterative partial least 
squares (NIPALS) algorithm that allows analysis of wide data matrices i.e. many variables 
(items) in comparison to number of subjects. OPLS uses a decline in Q2 (predictive fraction) 
to determine the number of independent (orthogonal) components to extract to avoid over-fit. 
Q2 is calculated by cross-validation [72, 73]. Variables of Importance for the Projection 
(VIPs) were listed. VIP is the sum over all model dimensions of the contributions VIN 
(variable influence). VIP with a value exceeding 0.8 with a confidence interval not including 
zero was considered to have influence on the projection. With multivariate methods, it is 
possible to investigate relations between all variables in a single context. When fitting an 
Orthogonal Partial Least Squares (OPLS) Projection to Latent Structures model, OPLS finds 
the linear (or polynomial) relationships between a matrix Y (response variables) and a matrix 
X (predictor variables) [74]. The significance testing was based on an ANOVA of the cross-
validated residuals (CV-ANOVA). The statistical software SIMCA P+©, version 12.0.1.0, 
Umetrics Ltd, Umeå, Sweden, was used. 
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6 MAIN RESULTS 
6.1 PHARMACOLOGICAL TREATMENT (I, II) 
6.1.1 Dispensed anti-asthmatic drugs for initiation of treatment (I) 
A total of 1033 children aged 0-16 years were initiated on anti-asthmatic drugs between July 
2006 and June 2007. Slightly more than half of the children (51 %) were aged 0-6 years. 
Most children (89 %) were initiated on SABA as monotherapy or SABA in combination with 
ICS. Among the preschool children (0-6 years), the majority (64 %) were initially dispensed a 
combination of SABA and ICS. SABA as monotherapy was most common among the 
school-aged children (in this study 7-16 years), where it was initially dispensed in 50 % of the 
children. Anti-asthmatic drugs other than SABA and ICS were dispensed in fewer than 8 % 
of the children. Table 8 shows the pattern of dispensed drugs for initiation of treatment. 
 
Table 8. Number of children with their first anti-asthmatic drugs dispensed between July 
2006 and June 2007 after a one-year drug-free wash-out period. 
1
SABA denotes short-acting beta2-agonists, 
2
ICS denotes inhaled corticosteroids, 
3
Fixed combination of ICS 
and LABA, 
4
LABA denotes long-acting beta2-agonists, 
5
Other combinations of the above mentioned drugs. 
 
Asthma treatment was initiated in primary care for 42 % of the preschool children and in a 
paediatric outpatient clinic for 52 %. Among the school-aged children 72 % received their 
asthma treatment from primary care while 16 % had their asthma treatment initiated in a 
paediatric outpatient clinic. Other health care providers such as hospital-based specialists or 
Drugs Children 
0-6 years 
n (%) 
Children 
7-16 years 
n (%) 
All children 
0-16 years 
n (%) 
SABA
1
 monotherapy 
 
159 (30) 250 (50) 409 (40) 
SABA
1
 and ICS
2 
 
338 (64) 165 (33) 503 (49) 
SABA
1
 and fixed combination
3 
 
1 (<1) 37 (7) 38 (4) 
ICS monotherapy 
 
24 (5) 24 (5) 48 (5) 
 
LABA
4
  monotherapy 
 
0 (0) 15 (3) 15 (1) 
LABA
4
, ICS
2
 and SABA
1 
 
0 (0) 7 (1) 7 (<1) 
Montelukast, monotherapy 
 
2 (<1) 2 (<1) 4 (<1) 
Other combinations
5 
 
6 (1) 3 (1) 9 (1) 
All patients initiated on therapy 
 
530 (100) 503 (100) 1033 (100) 
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school health care initiated asthma treatment in 6 % of the preschool children and in 12 % of 
the school-aged children. 
A total of 42 % of the children were only dispensed one prescription whereas 13 % had more 
than four prescriptions dispensed. The school-aged children had in general fewer 
prescriptions dispensed than the preschool children. Figure 3 shows the number of anti-
asthmatic drug prescriptions dispensed to each patient during the 24-month follow-up period. 
 
Figure 3. Number of anti-asthmatic drugs prescriptions dispensed to each child over a 24-month period 
 
6.1.2 Dispensed anti-asthmatic drugs in children with a recorded diagnosis 
of asthma (II) 
In total there were 2638 children aged 0-17 years during the baseline period and 2806 
children during the follow-up period with a recorded diagnosis of asthma that were dispensed 
anti-asthmatic drug treatment prescribed from primary care. The PHC intervention group was 
slightly larger than the control group. Figure 4 shows how the children with a recorded 
diagnosis of asthma that were dispensed anti-asthmatic drugs were allocated in the different 
groups. 
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Figure 4. Flowchart of children with asthma at the 28 included PHCs at baseline and follow-up. Some children 
may be included during both periods. 
 
There were no statistically significant differences in dispensed anti-asthmatic drug treatment 
between the intervention- and control group either at baseline or at follow-up. The majority of 
children with a recorded diagnosis of asthma were dispensed both SABA and an anti-
inflammatory anti-asthmatic drug (ICS, fixed combination or montelukast) (table 9). 
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Table 9. Primary health care centres (PHCs) before and after intervention. Data compared are 
number of children with dispensed anti-asthmatic drugs prescribed from included PHCs 
Age-
group 
Drug Children
5
 at baseline 
 N(%) 
Children
5
 at follow-up 
 N(%) 
  Intervention 
PHCs 
Control 
PHCs 
Intervention 
PHCs 
Control 
PHCs 
0-6 years SABA
1
 monotherapy 277(29) 163(30) 214(24) 125(24) 
 SABA
1
 and ICS
2 
588(62) 304(56) 538(61) 306(59) 
 SABA
1
 and fixed 
combination
3 
3(<1) 7(1) 0(0) 1(<1) 
 SABA
1
 and 
montelukast 
62(7) 51(10) 112(13) 70(14) 
 Other monotherapies 
or combinations
4 
20(2) 17(3) 19(2) 17(3) 
 Total 0-6 years 950(100) 542(100) 883(100) 518(100) 
      
7-17 
years 
 
SABA
1
 monotherapy 
 
158(21) 
 
62(16) 
 
164 (19) 
 
86(16) 
 SABA
1
 and ICS
2 
349(45) 150(40) 456(52) 267(51) 
 SABA
1
 and fixed 
combination
3 
120(16) 69(18) 89(10) 68(13) 
 SABA
1
 and 
montelukast 
45(6) 22(6) 85(9) 43(8) 
 Other monotherapies 
or combinations
4 
96(12) 75(20) 86(10) 61(12) 
 Total 7-17 years 768(100) 378(100) 880(100) 525(100) 
1
SABA denotes short-acting beta2-agonists, 
2
ICS denotes inhaled corticosteroids, 
3
Fixed combination of ICS 
and LABA (long-acting beta2-agonists),
4
Other combinations of the above mentioned drugs. 
5 
Children listed at included PHCs. 
 
A comparison of dispensed anti-asthmatic drugs prescribed by physicians in primary care 
versus other specialists in secondary care showed statistically significant differences in all 
drugs in both age-groups (p < 0.05) except for SABA and ICS in preschool children and 
other monotherapies or combinations in both age-groups. The children treated by specialists 
were in general dispensed less SABA as monotherapy, less SABA and ICS (school-aged 
children) and more SABA and fixed combinations and SABA and montelukast. This 
difference was shown both during the baseline period and the follow-up period.  
6.1.3 Documentation of asthma diagnosis in all children that were dispensed 
anti-asthmatic drugs prescribed in primary care (II) 
A diagnosis of asthma was recorded in 80 % of the children in the intervention group and in 
75 % of the children in the control group among all the preschool children that were 
dispensed anti-asthmatic drugs during the baseline period. Among the school-aged children 
the numbers were 70 % in the intervention group and 64 % in the control group. However, 
there was a statistical significant difference (p<0.001) between the intervention and control 
group in both age-groups at baseline. An evaluation of the intervention could thus not be 
done regarding this parameter. Among children who were dispensed anti-asthmatic drugs, the 
observation that a lower proportion of school-aged children than preschool children had a 
recorded diagnosis of asthma remained during the follow-up period. 
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Results in summary 
Treatment with anti-asthmatic drugs was mainly initiated in paediatric specialist clinics in 
preschool children and in primary care in school-aged children. Children of all ages with a 
recorded diagnosis of asthma were dispensed anti-asthmatic drugs according to the evidence-
based guidelines at baseline as well as at follow-up. The educational intervention did not have 
any effect. The majority of the children with a diagnosis of asthma were thus dispensed 
SABA as well as anti-inflammatory anti-asthmatic drugs. However, approximately one-
fourth, among school-aged children even more, was dispensed anti-asthmatic drugs without 
having a recorded diagnosis of asthma. More than 50 % of the school-aged children were 
mainly dispensed SABA at one single occasion when there was no connection to diagnosis.     
6.2 APPROACH TO, LEARNING FROM AND USE OF EVIDENCE-BASED 
GUIDELINES IN THE CONTEXT OF PRIMARY CARE (III) 
 When the FGIs were analysed three themes were conceptualised that described how GPs 
approach and learn from the guidelines in their daily practice. These themes and the 
categories that supported them are shown in figure 5. 
 
Figure 5. Categories identified during the content analysis and the corresponding interpreted themes.  
 
Learning to use guidelines by interactive contextualised dialogues. Collaboration and 
learning by dialogue with colleagues at the own PHC as well as with secondary care was 
considered as the optimal way to assess knowledge. Learning obtained by interaction and 
thus encouraging reflection was perceived by the GPs to give a better quality of care. The 
GPs also felt that group-dialogues created power in decision-making. A more developed 
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cooperation between primary and secondary care when developing the guidelines was 
suggested as a way to make the guidelines more supportive and open to individualisation 
depending on the clinical situation. This can be exemplified by the citation: 
“ When the guidelines were to be updated all the GPs were invited to a meeting…They 
explained the guidelines and why they have updated them, how we should handle the patients, 
when to refer them to secondary care and planned follow-up. It was a short presentation 
followed by a long dialogue…” - Female 
Learning that establishes confidence to provide high quality care. Confidence was a 
central aspect for the GPs in using guidelines. To feel confident in own knowledge by 
confirming it in guidelines was important for the GPs in the decision-making process. 
However, an important aspect was also that they could confirm that their decision was 
evidence-based for the patient and thus had a potential to increase the patients´ motivation 
and knowledge. 
A prerequisite for using the guidelines was that the GPs felt that they could rely on them. The 
GPs felt the greatest reliability from consulting someone they knew personally. Reliability in 
internet-based or printed guidelines was strongly dependent on the source being well known 
and the guidelines being continuously updated. 
When new guidelines were established the GPs wished for individualised follow-ups from 
secondary care on how their use of the guidelines actually improved the care of the patients. 
The GPs meant that an evaluation of the individualised results in an audit-like model would 
be stimulating and strengthen confidence in the guidelines. This can be exemplified by the 
citation: 
“ I would like to see results. I think that one reason for not following the guidelines is that we 
never have follow-ups. I want follow-ups, personal follow-ups. We hardly ever get feedback 
on what we do. The client health care organisation has organised follow-ups which I think is 
good because then you get feedback. If I never get feedback on what I am doing… why should 
I care ??” - Female 
Learning by use of relevant evidence in the decision-making process. A major problem in 
using the guidelines was to find the relevant information for the decision in each specific 
clinical situation.  
Printed or internet-based guidelines should be short and concise with a clear over-view and a 
pedagogic lay-out. There should be links or references to in-depth literature to consider later 
if needed. Furthermore, guidelines sorted by symptoms instead of diagnoses would be more 
appropriate for decision-making. Lectures should be arranged in small groups. 
The GPs have a clinical situation where their working- days usually are fully booked with 
patient-visits. The patients present a wide spectrum of diseases which sets high requirements 
for accessibility of guidelines. Slow electronic systems and insufficient information retrieval 
skills made many GPs prefer short printed brochures, easily accessible lying on the desk. 
Phone consultations with secondary care, if accessible only during certain times of the days 
were not used. However, GPs who had free access to phone consultations perceived them as 
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the most valuable form of guidelines in difficult cases. The importance of easily accessible 
guidelines could be exemplified by the citation: 
“ I feel that the biggest problem with internet is lack of time. I lose control of time when I am 
searching for information on the internet and then I feel stressed having to keep track of 
time.”Oh God there is so much information, where should I start”…” - Female 
Results in summary 
The possibilities of learning when using guidelines for interactive contextualised dialogues 
and learning that provides confidence in high quality care were emphasised by participating 
GPs as important aspects to consider in their approach to the guidelines. A prerequisite for 
using the guidelines was that they should allow access to relevant evidence in the decision-
making process. 
6.3 THE INFLUENCE OF CONTEXTUAL FEATURES ON QUALITY OF CARE 
(IV) 
6.3.1 Quality of care 
The documentation of the quality indicators shown in table 6 varied between the PHCs. 
Documentation of fulfilled asthma criteria for children with a recorded asthma diagnosis was 
present in all electronic health care records in all PHCs. Documentation of pharmacological 
treatment or consultation with a paediatrician was also documented in most children with a 
recorded diagnosis of asthma. Documentation of other quality indicators showed a large 
variability which resulted in a widespread distribution of CQI between the PHCs. Table 10 
illustrates the documentation of quality indicators and how it affected CQI. 
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Table 10. Quality indicators documented in the electronic health care records and the  
corresponding calculated CQI. 
 All PHCs 
 
n=14
 
The PHC with 
the lowest CQI 
 n=1 
The PHC with 
the highest CQI 
 n=1 
CQI 4.04 (3.14-4.72) 2.75 
 
7.34 
Contribution of the indicators 
of quality to CQI 
   
Diagnostic criteria for asthma 
fulfilled 
1.00 (1.00-1.00) 1 1 
Documentation in patient 
history:  
   
History of allergy 0.42 (0.39-0.48) 0.40 0.50 
Heredity of asthma and 
allergy 
0.42 (0.39-0.48) 0.40 0.50 
Exposure to furred pets 0.23 (0.20-0.28) 0.05 0.48 
Exposure to tobacco 0.20 (0.05-0.30) 0.05 0.80 
Diagnostics and patient 
support:  
   
PEF performed 0.36 (0.23-0.40) 0.10 0.46 
Spirometry performed 0.26 (0.10-0.52) 0 1.00 
Patient education 
offered 
0.20 (0.04-0.25) 0 0.80 
Inhalation technique 
demonstrated 
0.18 (0.10-0.26) 0 0.80 
Patient education 
offered 
0.20 (0.04-0.25) 0 0.80 
Pharmacological 
treatment/Consultation: 
 
 
 
 
 
 
Treatment with inhaled 
corticosteroids or 
paediatrician consulted 
0.82 (0.75-0.91) 0.75 1 
Values for all PHCs are given as median (interquartile range) 
 
6.3.2 The influence of contextual features 
The OPLS analysis identified ten contextual features with influence on CQI. The following 
contextual features were associated with the highest positive influence on CQI: 
 Lower reported age-limit for performing spirometry 
 More reported time scheduled for asthma care 
 Lower reported duty-grade for GPs 
 Higher activity level at seminars 
 All the ten features and their influence on CQI are shown in figure 6. 
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Figure 6. Contextual features with influence on CQI. Black bars indicate positive and striped bars indicate 
negative influence. 
 
Possession of equipment to perform lung function tests (PEF-meter, spirometer) or 
performing spirometry regularly in children did not have any influence on CQI. Nor did 
having inhaler devices for demonstration or patient education material or material regarding 
smoking cessation. 
PEF performed regularly had influence on CQI while spirometry performed regularly had 
not. The variable “spirometry performed regularly” had a value exceeding 0.8 and is shown 
in figure 6 but the confidence interval for this variable included zero and this variable could 
thus not be considered as having influence on CQI. 
A GP or nurse with assigned responsibility for asthma care did not have any influence on 
CQI, neither did attendance rate at the seminars. 
Sociodemographic factors did not have any influence on CQI. 
Results in summary 
We found ten contextual features that influenced the PHCs adherence to the evidence-based 
guidelines for children with asthma. An evidence-based care of children with asthma was 
found to require allocated time, interprofessional collaboration and an organisational structure 
supporting engagement and professional development adjusted to the local conditions.  
  35 
7 DISCUSSION 
This thesis focuses on potential influence of quality of management and learning on 
evidence-based practice for children with asthma in primary care as shown in figure 7. 
 
Figure 7 . The process from evidence-based medicine (EBM) to evidence-based practice (EBP) and factors that 
influence this process. 
 
In study I we showed that physicians initiating school-aged children on anti-asthmatic drugs 
had poor adherence to the evidence-based guidelines. However, in study II when we only 
included children with a recorded diagnosis of asthma, the adherence to the guidelines 
regarding pharmacological treatment was good. Still, especially among the school-aged 
children, a large proportion of all children that were dispensed anti-asthmatic drugs did not 
have a recorded diagnosis of asthma. 
Even if evidence-based guidelines are based on a diagnosis of asthma, pharmacological anti-
asthmatic treatment was apparently not exclusively given to children that had an asthma 
diagnosis. In study III we therefore wanted to explore the GPs´ attitude to guidelines in 
general. We found three themes to consider, regarding how GPs approach, learn from and use 
evidence-based guidelines in their daily decision-making process. The themes emphasised the 
importance of: 1. Learning to use guidelines by interactive contextualised dialogues. 
2. Learning that establishes confidence to provide a high quality care. 3. Learning by use of 
relevant evidence in the decision-making process. 
The implementation of evidence-based guidelines in the complex context of primary care is 
thus a challenge. In study IV we identified ten contextual factors with influence on quality of 
care.  
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7.1 EVIDENCE-BASED PRACTICE AND PHARMACOLOGICAL TREATMENT 
(I, II) 
Evidence-based guidelines presuppose a diagnosis [6, 7, 10]. Yet, in many studies that show a 
poor adherence to the guidelines, the children did not, in similarity with study I, have a 
recorded diagnosis of asthma [75-78]. Children in these studies were mainly prescribed [75-
77] or dispensed [78] short or long-acting beta2-agonists as monotherapy. However, there are 
studies that show poor adherence to the guidelines with an under-use of anti-inflammatory 
anti-asthmatic drugs, even when the children had a recorded diagnosis of asthma [79, 80]. In 
both these studies the study periods were short, only 12 months. Such a short study period 
may result in the confounder that the children still are able to use drugs prescribed and 
dispensed before the study period. Asthma as well as other atopic diseases runs in families 
[81]. Another confounder could thus be that members in a family may use each other´s 
medicine which in turn may lead to fewer own dispensed anti-asthmatic drugs if the 
observation period is not long enough. A Swedish study performed in adolescents (11-14 
years) has shown that an 18-month period was needed when using dispensing data to study 
the use of anti-asthmatic drugs [82]. 
In study II when the children had a recorded diagnosis of asthma and were followed for 24 
months, more than 65 % of the children were dispensed SABA and an anti-inflammatory 
anti-asthmatic drug. We have thus shown that physicians in primary care, treating children 
with a recorded diagnosis of asthma have a good adherence to pharmacological evidence-
based guidelines. The good adherence to the evidence-based guidelines already at baseline 
probably also explains why the educational intervention did not have any effect on the 
pharmacological treatment. 
The difference in dispensed anti-asthmatic drugs between children treated in primary and 
secondary care in study II was expected. Our experience is that the main purpose of treating 
children in secondary care is that the asthma is too severe to be managed in primary care. 
Consequently children treated in secondary care should need a higher level of treatment (table 
1 and 2). 
In the second part of study II, we showed that a large proportion of all children that were 
dispensed anti-asthmatic drugs prescribed in primary care did not have a recorded diagnosis 
of asthma. This observation was especially obvious among the school-aged children. 
A possible explanation to this could be that SABA was used partly as a diagnostic tool. This 
hypothesis has also been proposed in other studies [83]. Still, SABA as a diagnostic tool for 
asthma should rather have been expected in preschool children since the possibilities to 
perform lung function tests in this age-group are more limited than in school-aged children. 
On the other hand, preschool children usually have more obvious symptoms of the disease of 
asthma than school-aged children [2, 31].  
These arguments are supported by our findings in study I. In this study there was no 
connection to diagnosis and it could thus be expected that both children with and without a 
diagnosis of asthma were included. In this study we showed that only 47 % of all the school-
aged children that were initiated on anti-asthmatic drugs were initiated on any kind of anti-
inflammatory anti-asthmatic drug. Less than 10 % had more than four prescriptions of anti-
  37 
asthmatic drugs dispensed during the 24 months the pattern of dispensed drugs was followed. 
More than 50 % were mainly dispensed SABA at one single occasion. In preschool children 
65 % were initiated on anti-inflammatory anti-asthmatic drugs. Almost 20 % had more than 
four prescriptions of anti-asthmatic drugs dispensed during the 24 months the pattern of 
dispensed drugs was followed.  
We excluded SABA administered as oral solution in study I and in the second part of study 
II. It is our experience that oral solutions of SABA often are used as antitussive medication or 
as a diagnostic tool for asthma in preschool children. Still, SABA administered by inhalation 
was included. To administer anti-asthmatic drugs by inhalation is more complicated in 
preschool than in school-aged children. This may also be a reason for the lower proportion of 
children with a reported diagnosis of asthma among the school-aged children. 
Our hypothesis was thus that dispensed anti-asthmatic drugs without a recorded diagnosis of 
asthma consisted mainly of SABA as monotherapy, dispensed at one single occasion as a 
diagnostic tool. Consequently, it is reasonable to believe that some of the school-aged 
children that were dispensed SABA as monotherapy at one single occasion did not have a 
diagnosis of asthma. However, according to the evidence-based guidelines spirometry should 
be performed as far as possible to diagnose asthma in school-aged children [10]. 
Other studies [84-86] have shown that asthma medication may function as a proxy for asthma 
diagnosis. In all these studies SABA as oral solutions were excluded. Further, in order to 
serve as a proxy for asthma diagnosis, the anti-asthmatic drugs should have been dispensed at 
least twice [85, 86] or should have been redeemed according to very strict regulations [84]. 
Even if dispensed drugs reflect patient use better than prescribed drugs do, it does not mean 
that the patients actually take their medication. A qualitative interview study with children 
and adults with asthma has explored barriers and facilitators to adherence to long-term daily 
maintenance treatment for asthma [87]. The study concluded that factors could be interpreted 
as barriers or facilitators depending on the context. Patient education was an example of this. 
Good knowledge about the medication was pointed out as the key facilitator in adherence to 
drugs prescribed. Poor knowledge about the medication instead lead to feelings of uncertainty 
regarding effects and side-effects and thus to poor adherence. Crucial for adherence to anti-
asthmatic drug treatment was the quality of the patient-physician interaction and the health 
care system accessibility. 
7.2 EVIDENCE-BASED GUIDELINES  -  APPROACH TO, LEARNING FROM 
AND USABILITY IN THE DECISION-MAKING PROCESS (III) 
To make correct clinical decisions for each individual patient is the goal for all physicians in 
their daily practice. The three conceptualised themes could in different ways be linked to the 
decision-making process according to the Dual Process Theory [20-22] shown in figure 8. 
The importance of dialogue in the decision-making process in clinical practice was the main 
finding in the first theme “- Learning to use guidelines by interactive contextualised 
dialogues”. Pattern recognition is central in the dialogue as shown in figure 8. Applied to the 
Dual Process Theory as described by Croskerry [20] the dialogue could enhance the 
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repetitive process of the analytic system and increase the process of pattern recognition. 
Pattern recognition thus enables a future fast, but still evidence-based decision-making 
process [20-22]. The opposite, strictly detailed instructions without possibilities for 
reflections, may instead hinder the learning process. 
The importance of professional networks and feedback in decision-making has been pointed 
out in other studies [19, 88]. Further, evidence-based guidelines designed as rigid, detailed 
instructions were perceived by the GPs as assignments instead of being part of a continuous 
learning process. Other studies have shown that physicians´ attitudes towards guidelines are 
strongly correlated with access to professional networks [88]. Dialogue, feedback and time 
for reflection are thus central to determine whether the evidence-based guidelines should be 
perceived as facilitators or barriers [37, 38, 42, 89, 90]. 
Dialogue and feedback were essential in GPs´ approach to the guidelines in the decision-
making process. Still, a prerequisite for using evidence-based guidelines at all was that the 
GPs perceived them as trustworthy. Otherwise there was an apparent risk that the GPs would 
rely on experience rather than on guidelines in the decision-making process. 
To obtain a balance between the fast intuitive system and the slower analytic system in the 
decision-making process was central in the second theme “- Learning that establishes 
confidence to perform a high quality of care”. Confidence could be obtained by confirmation 
of own knowledge if the source was perceived as reliable. Further, if the GPs had the 
possibility to evaluate own results this could lead to a positive attitude towards the guidelines 
and promote behavioural changes. Previous studies have shown that to get feedback and to 
feel confident in own competence strengthen intrinsic motivation and promote behavioural 
changes [91]. Thus, if the GPs felt confident in the use of the analytic system they could 
switch between the two systems as needed. Confidence thus promotes a decision-making 
process that strives towards evidence-based practice.  
To feel confidence in the evidence-based guidelines is necessary for the GPs in order to learn 
from them and to integrate them in their decision-making. Yet, there is a vast amount of 
information available while lack of time is a reality in clinical practice. To find relevant 
information was therefore the main finding in the third theme “- Learning by use of relevant 
evidence in the decision-making process”. The guidelines should be easily accessible with a 
clear design and lay-out. Further, they should be short, simple and preferably include patient 
leaflets. The guidelines should also include references to in-depth literature. Easy access to 
relevant guidelines encourages the use of the analytic system in the decision-making process 
and thus promotes a high quality of care. Previous studies have pointed out the importance of 
accessibility [92] and that evidence-based guidelines must be designed to facilitate the 
decision-making process [93, 94].  
To use the least cognitive effort,” the cognitive miser” [20-22], in the decision-making 
process was a necessary strategy for the GPs in their clinical routine practice where a high 
efficiency is required. However, too little cognitive effort increases the risk of diagnostic 
errors. A previous study has also shown that diagnostic errors are common [95, 96]. Most 
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common were diagnostic reasoning errors when the physicians were not aware that there 
actions were incorrect. We think that it is important to consider the decision-making process 
when developing and implementing evidence-based guidelines. Further, we found that the 
contextual features of primary care are highly important in how GPs approach, learn from 
and use the guidelines in their daily clinical routine practice. 
 
Figure 8. The decision-making process with the phases reinforced by the themes marked.  
Intuitive system here includes general practitioners earlier experience and the context of the primary health care 
centres. 
Analytic system here includes evidence-based guidelines, consultations and evaluation of own results 
This figure is inspired by Patrick Croskerry [20]. 
7.3 INFLUENCE OF CONTEXTUAL FEATURES ON EVIDENCE-BASED 
PRACTICE (IV) 
To understand the influence of contextual features is essential in understanding how the 
guidelines are used in clinical practice. We studied in total 26 contextual features in primary 
care. By using the OPLS method [72-74], a multivariate regression analysis, it was possible 
to evaluate the influence of contextual features on quality of care defined as CQI. We could 
identify ten contextual features with influence on quality of care, thus reflecting adherence to 
evidence-based guidelines to paediatric asthma. These features included organisational 
characteristics as well as engagement in asthma care but no socio-demographic 
characteristics. 
Reported hours scheduled for asthma care, duty grade for GPs, activity at seminars and 
reported lower age-limit for performing spirometry were all contextual features with a high 
influence on CQI. All these features represent a well structured organisation and/or 
engagement. A management that supports interprofessional collaboration and engagement is 
necessary to make scheduled time for asthma care possible [97, 98]. Further, allocated time 
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for asthma care is important which also has been shown in other studies [60]. Simply having 
a GP and/or nurse with assigned responsibility for asthma care was not enough to influence 
CQI. A high duty grade influenced CQI negatively. The financial reimbursement system in 
Swedish primary care is built on productivity [13, 99]. GPs working fulltime or almost 
fulltime in clinical practice could thus be expected to have little time for reflection which 
could explain the negative influence on quality of care. Being very preoccupied with clinical 
routine practice could also make the GPs less prepared for organisational demands and 
engagement [51]. Activity level at seminars reflected engagement in asthma care as well as a 
local workplace culture with interactivity both uni- and interprofessionally. Interprofessional 
education in general has been shown to stimulate collaborative practice. It optimises the skills 
of the professions and may lead to improved health outcomes [100]. To perceive that the own 
PHC regularly performed spirometry in children from age nine had an influence on CQI. We 
interpreted this as a marker of local knowledge and engagement in asthma care which in turn 
indicated a supportive management. 
There could have been several possible reasons that the other six contextual features had less 
influence on quality of care. Influence, but during a limited period of time, such as change of 
medical software and vacancies could be one reason. Contextual features requiring 
engagement from only one single GP or nurse, such as distribution of patient education 
material and smoking cessation material could be another reason. 
In contrast to other studies [101-103] socio-demographic features did not have any influence 
on quality of care. However, these studies used individual data while we only had access to 
data on group level which could be a possible explanation. 
Primary care is a complex part of health care. There are demands from the health care 
principals as well as from secondary care. Further, primary care collaborates with many 
different units in secondary care which in turn have different requirements and expectations. 
There is a substantial gap between actual care provided in primary care and evidence-based 
guidelines [41]. This gap is especially prominent regarding non-pharmacological treatment. 
In this study 58 % of the study population was treated with ICS while only 14 % had patient 
education and demonstration of inhalation technique documented. Unlike patient education 
and demonstration of inhalation technique, prescription of pharmacological treatment is not 
dependent on contextual features. Consequently, pharmacological treatment is less 
complicated to discuss. It was also our experience from the educational seminars that 
pharmacological treatment initially was the subject that most of the PHCs wished to discuss. 
However, to consider contextual features is necessary in order to apply evidence-based 
guidelines to clinical routine practice. It is thus important with a management that is aware of 
and creates opportunities to improve important contextual features with high influence on 
quality of care. Further, it is also important that evidence-based guidelines are designed as 
frameworks that can be adapted to the different contextual features at the individual PHCs.  
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7.4 METHODOLOGICAL CONSIDERATIONS 
One important factor to consider in research is that the study material is representative. 
Health care professionals from 20 primary health care centres had shown an active interest in 
paediatric asthma by attending a seminar. Six of these PHCs declined to participate in the 
study with the motivation that they did not agree to let us study their documentation of the 
quality indicators in the electronic health care records. The remaining 14 PHCs that were 
included in all our studies could thus be expected to have a genuine interest in improving the 
quality of care of children with asthma. There was thus a selection bias, i.e. the association 
between exposure and interest of paediatric asthma may have differed between those PHCs 
who participated, and those PHCs who did not participate in the study [104]. 
However, there was no difference in dispensed anti-asthmatic drugs in children with a 
diagnosis of asthma in these 14 PHCs and the 14 PHCs that were matched controls in study 
II. These 14 PHCs were selected from registers where we had no reason to expect bias. 
We cannot exclude influence of selection bias in the remaining three studies. Still, in that case 
it is reasonable to believe that adherence to evidence-based guidelines in children with 
asthma should rather be worse in primary care in general than our studies show. 
Another important factor to consider is if the study material remains stable when different 
aspects are studied or compared. In study II we excluded PHCs from being selected to the 
control group if any of the GPs in the 14 PHCs in the intervention group had switched to 
them during the period of, or after the intervention. There were only two GPs that switched to 
a PHC outside the intervention group during the study period. It was not possible to check if 
other physicians such as residents had switched between the two groups. There were few 
children that switched PHCs between the groups during the study. These few children were 
excluded. 
More than half of all the physicians at the PHCs participated in all three educational 
seminars. Still, there could also have been other physicians documenting the quality 
indicators in the electronic health care records (study IV). 
Not having a stable study material can lead to a confounding bias [104]. However, our studies 
were performed in clinical routine practice and it is a reality in routine practice that neither 
physicians nor listed children remain unchanged over time. Clinical studies like ours must 
often be pragmatic with practical circumstances and consequences considered [53-55]. 
To investigate evidence-based practice in primary care is a challenge with many different 
aspects. Therefore we have chosen to combine several methods and to use different 
quantitative methods in study I, II and IV and a qualitative method in study III. 
Using register-data as we did in study I and II give very reliable data regarding dispensed 
drugs, connection to diagnoses and possibilities to follow children over time. 
In these studies we got data regarding dispensed anti-asthmatic drugs from the Swedish 
Prescribed Drug register which has more than 99% coverage of all dispensed drugs [64]. In 
both studies, but especially in study II a large number of children were included which 
should make our results representative for primary care. Still, we did not have data on 
prescribed or used drugs. Not having data regarding prescriptions may underestimate 
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prescribers´ decision-making and thus adherence to guidelines. However dispensed drugs 
provide a better picture of patient use than data on issued prescriptions since it also reflects 
patient behaviour. 
Besides very few exceptions, all encounters and diagnoses in primary care are reported and 
stored in GVR/VAL [65]. Still, it is important to be aware of that the diagnostic accuracy 
may vary between different practices and over time and there is no information on how 
diagnostic criteria are followed. Furthermore, data retrieved from registers is secondary data, 
which means that the data is not collected for the specific research purpose [105]. This may 
cause a possible bias in recording of diagnoses and thus variability in data quality. 
The socio-demographic characteristics were compared as CNI [56]. However, CNI is based 
on the characteristics in the geographic area while people in the Stockholm region since 2008 
have a free choice of primary care [13]. 
In study II when looking at the pattern of dispensed drugs over time  it seemed as a 
difference regarding some of the drugs in both the intervention and control group (table 9). 
However, this was a pragmatic study and individual children may have been included both 
during the baseline and the follow-up period. There was thus no suitable statistical method 
available to compare the groups over time. In general SABA and montelukast were more 
dispensed in preschool children in both groups during the follow-up period. In school-aged 
children SABA and ICS were more dispensed while SABA and fixed combinations as well as 
other therapies and combination were less dispensed in both groups at follow-up. Given the 
design of the study we cannot explain the observed difference. Our observation period was 
quite long, between 2006 and 2012. During this period of time there were new treatment 
recommendations that introduced  montelukast as an alternative to ICS in low dose. Further, 
there were financial incentives as well as specific education that emphasised the prescription 
of SABA and ICS before trying SABA and fixed combination.  
In study IV we assessed information of quality of care documented in electronic health care 
records. These data assessed what was documented, which does not necessarily reflect 
exactly what was performed. We might therefore have assessed a low quality of 
documentation in addition to a low quality of care. However, documentation of asthma 
criteria was fulfilled in all children with a diagnosis of asthma, which is not in accord with a 
low quality of documentation. 
Data regarding contextual features was mainly retrieved with help of predefined checklists. 
One person with good knowledge of the routines at each PHC was assigned to fill in the 
checklist. Still this approach might result in under- as well as overestimation of the contextual 
features. 
It is a real challenge to measure quality of care. If the quality indicators had been assessed 
separately, the material of a single PHC would have been too small to assess. Scores for 
individual quality indicators require very large samples for a reliable assessment according to 
Kirk [29]. In our study there would have been a risk for significant differences by chance if 
multiple quality indicators had been compared between the PHCs. By combining single 
quality indicators into a composite quality indicator (CQI) much smaller samples are required 
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to give reliable data [29]. 
The traditional statistical methods often focus on comparisons of single factors. The OPLS 
analysis enabled us to make an overall evaluation of which of all the contextual features that 
had an influence on CQI. 
In study III the purpose was to explore how GPs feel, think and act when they use evidence-
based guidelines. Qualitative research methods should be applied to explore research 
questions like this. 
In qualitative research it is important to collect enough data i.e. until no more new data is 
gained. It is therefore important to choose a method applicable to the study material. We 
chose focus group interviews since this is a suitable method to get a rich amount of data when 
there is a group of people with the same background [106]. Further, FGIs have proven to be a 
useful method to explore thoughts and feelings underlying behaviour [107, 108]. 
We performed four focus group interviews with between three and eight participants in each 
FGI. The ideal size of a FGI for noncommercial topics is five to eight persons [106]. The 
disadvantage of smaller groups is that the range of experiences is limited. Smaller groups can 
on the other hand make the participants feel more comfortable which facilitates discussing in-
depth topics as we did. In the two FGIs with the lowest number of participants (three and four 
respectively) all the participants were GPs with special interest in paediatric asthma and the 
discussions were vivid. We performed FGIs until we did not gain any new data. It is thus 
reasonable to believe that the qualitative data we collected in the topic was representative for 
GPs in primary care.  
The interviewer (moderator) was known to the participants while the observer was not. It is 
recommended to have a moderator that shares the same characteristics as the participants in 
order to make them feel more comfortable [109] when discussing in-depth topics. To have an 
interviewer that is known to the participants could increase the risk for valuing the data 
during the interviews and missing key-points. To have an objective observer that assisted in 
summarising the key-points at the end of the discussion should have minimised that risk. 
It is important to be aware that interviews only give data regarding what people say they do, 
not what they do in practice. To increase the validity between “saying and doing”, questions 
can be asked that reflect the participants´ way of acting [68]. We did this in our interviews by 
frequently using probing follow-up questions where we asked for concrete examples. 
Content analysis is a suitable method in analysing qualitative data when the research 
questions are defined and not too extensive [110] as it is in a focus group interview. Since we 
had a large amount of data we considered an inductive content analysis [110] as the most 
suitable where the categories and themes are derived from the data collected. Content 
analysis according to Graneheim and Lundman [70] is an example of this. 
To evaluate the results in qualitative research one must ensure the trustworthiness of the data 
[111]. This means that the data obtained should have emphasis on authenticity by being 
balanced, fair and conscientious in taking account of multiple perspectives, interests and 
realities [112]. In order to obtain trustworthiness the aspects of credibility and dependability 
and transferability should be considered [70]. Credibility deals with the focus of the research 
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and how well data and processes of analysis address the intended focus [111]. Dependability 
deals with instability i.e. to which extent data change over time. A large amount of data 
collected over a long period of time increases the risk for inconsistency and thus decreases 
the dependability [112]. Transferability includes a careful description of the sample setting, 
data collection and analysis process in order to make the findings transferrable to similar 
groups of GPs [111].  
There are several aspects that contribute to the trustworthiness of this study. The GPs were 
selected from PHCs that had an active interest in paediatric asthma and further education. 
Even if two of the FGIs were performed day-time at the PHCs the participation in the FGIs 
was voluntary. The sampling procedure should thus have been purposive in order to obtain 
rich and illuminative information [113]. All the FGIs were performed within seven months 
which should increase the dependability [112]. To ensure credibility all the authors, who had 
different backgrounds and perspectives, performed the content analysis and discussed 
categories and themes until consensus was obtained. Quotations were selected from the 
original interviews to illustrate the results and to further improve the credibility of the study. 
Finally the sample setting, data collection and process of analysis were carefully described in 
order to ensure transferability. Results from qualitative studies are not generalisable to other 
areas. However, included physicians represented a wide range in years in profession in 
primary care and men as well as women were represented. Further, they represented PHCs 
run by private as well as public actors and the PHCs had a wide-spread range of size and 
socio-demographic characteristics measured as care need index. The transferability of our 
results to PHCs in other regions of Sweden could therefore be expected to be good. 
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8 CONCLUSIONS 
Based on the results of this thesis we have made the following conclusions regarding GPs´ 
adherence to evidence-based guidelines for children with asthma: 
 GPs´ have a good adherence to the evidence-based guidelines regarding 
pharmacological treatment for children with a recorded diagnosis of asthma. It is 
important that studies regarding adherence to the guidelines for children with asthma 
are based on a study population with a recorded diagnosis. Anti-asthmatic drugs are 
partly used as diagnostic tools.To use spirometry more often in children from school-
age could be a way to minimise this.   
 The children with asthma received an anti-asthmatic treatment according to the 
guidelines already at baseline. An effect of the educational intervention could thus 
not be evaluated. 
 The following aspects are important when developing and implementing evidence-
based practice: Contextualised dialogue, based on the GPs´own experiences, 
feedback on own results and easy access to short guidelines perceived as trustworthy. 
Dialogue and interactivity, both within primary care and between specialties 
encourage reflection which is necessary in the process of learning. 
 Evidence based care in children with asthma could be facilitated by allocating time, 
by improved interprofessional collaboration and by creating an organisational 
structure that gives opportunities for engagement in asthma care. To support these 
contextual features is important in order to obtain a high quality of management of 
children with asthma.  
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9 CLINICAL IMPLICATIONS AND FUTURE 
PERSPECTIVES 
For a majority of the school-aged children and a large proportion of the preschool children 
their treatment with anti-asthmatic drugs is initiated in primary care. It is therefore important 
to establish an evidence-based practice in paediatric asthma in primary care. First, it is 
necessary, as far as possible, to aim for a diagnosis in the management of asthma. All PHCs 
should perform spirometry routinely on wide indications in all children from school-age. A 
management that supports interprofessional collaboration and provides allocated time is a 
prerequisite for performing spirometry routinely. A structure supporting these contextual 
features at each PHC could in turn facilitate fulfilment also of other important quality 
indicators. Examples of such quality indicators are: discussing smoking cessation/tobacco 
exposure, demonstrating inhaler device and providing patient education. 
Secondly, a shared knowledge-base for physicians and nurses is important. We have 
identified important aspects with potential to increase learning and usability of the evidence-
based guidelines. Contextualised dialogues, feedback and confidence could be obtained by 
encouraging and allocating time for regular meetings focused on peer-learning at the PHCs. 
Modern technology such as video-conferences regularly could facilitate for GPs and nurses to 
participate in educational meetings arranged by secondary care. This could in turn encourage 
dialogue between primary and secondary care. 
Evidence-based guidelines should preferably be gathered at one common site and have a 
clear design and lay-out. They should be designed as frameworks emphasising important key-
points instead of giving strict instructions. This could make them easier to adapt to the local 
context and could inspire the GPs to reflect in the decision-making process. 
GPs need to play a part continuously through the process of developing, implementing and 
updating the evidence-based guidelines. Their expertise in the feasibility of the guidelines is 
necessary to implement evidence-based medicine into evidence-based practice. 
The future perspectives, based on this thesis, are that studies are needed to further increase 
the understanding of effective learning strategies to integrate evidence-based guidelines in the 
decision-making process. Our learning strategy, case-method learning, could not be evaluated 
in this study since adherence to the quality indicator that we wanted to evaluate was good 
already at baseline. However, using the case method learning strategy to evaluate quality 
indicators with poor adherence at baseline, such as discussing smoking cessation/ tobacco 
exposure or performing spirometry could be an interesting future project.  
We have identified contextual features that influence evidence-based quality of care and we 
have seen that some features have more influence than others. A future perspective is to study 
how contextual features may affect each other. Further studies are thus needed to explore the 
relationship between contextual features and evidence-based practice in more detail.  
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10 SAMMANFATTNING PÅ SVENSKA 
Bakgrund 
Astma är den vanligaste kroniska sjukdomen hos barn i Sverige. Man uppskattar att 8-10 % 
av alla barn i skolåldern har astma. Astma hos förskolebarn (0-6 år) respektive hos skolbarn 
(7-17 år) ter sig olika både avseende symtom och prognos. Förskolebarn får ofta tydliga 
symtom enbart i samband med förkylningar. Astman har då god prognos och kan växa bort, 
ofta redan i 3-4 årsåldern. Detta gäller de barn som inte har några allergier. Barn i skolåldern 
med astma har i hög utsträckning en bakomliggande allergi, ofta mot perenna 
luftvägsallergener, t. ex pälsdjur eller kvalster. Dessa barn kan ha mer diffusa symtom i form 
av trötthet eller dålig fysisk ork. Astmasymtom i form av andningsbesvär, hosta eller ”pip i 
bröstet” kommer vanligtvis i samband med ansträngning och astman kan därför lätt feltolkas 
som enbart ansträngningsastma. Hos alla barn med andningsbesvär i någon form bör man i 
sjukhistorien och vid kroppsundersökningen därför efterforska tecken på allergier. Hos alla 
skolbarn med misstänkt astma och på vida indikationer hos förskolebarn bör allergiutredning 
utföras. Från skolåldern bör även lungfunktionsundersökning i form av spirometri utföras i 
diagnostiskt syfte. Detta är viktigt, då astma med samtidig allergi mot perenna 
luftvägsallergener ska betraktas som en kronisk sjukdom med behov av förebyggande 
underhållsbehandling med anti-inflammatoriska läkemedel mot astma. I handläggningen av 
barn med astma ingår också utvärdering av försämrande faktorer såsom tobaksexponering 
och pälsdjursexponering. Ett högkvalitativt omhändertagande av barn underlättas av en 
interprofessionell samverkan, vanligen mellan läkare och sjuksköterska. 
De flesta skolbarn med lindrig till måttligt svår astma men även många förskolebarn med 
lindrig astma handläggs inom primärvården. För att upprätthålla en hög vårdkvalitet finns 
evidensbaserade behandlingsriktlinjer utarbetade för primärvården. 
Behandlingsriktlinjerna är vanligtvis utformade som diagnosspecifika instruktioner, ofta 
tillgängliga via internet men även som broschyrer eller regelrätta skriftliga vårdprogram. 
Behandlingsriktlinjerna uppdateras regelbundet. Trots att behandlingsriktlinjerna är väl 
underbyggda har tidigare studier visat att följsamheten till dem generellt är låg. 
Det övergripande syftet med avhandlingen var att undersöka det evidensbaserade 
omhändertagandet av barn med astma i primärvården Vi ville utvärdera kvaliteten på 
omhändertagandet samt effekter av lärande på följsamheten till de evidensbaserade 
behandlingsriktlinjerna. 
Avhandlingen är baserad på följande fyra studier: 
Studie I: Adherence to guidelines for drug treatment of asthma in children; potential 
for improvement in Swedish primary care. 
Syfte: Att studera utköpsmönstret av astmaläkemedel för barn med astma i relation till de 
evidensbaserade behandlingsriktlinjerna. 
Metod:  En retrospektiv observationsstudie. Receptutköpsdata för alla barn 0-16 år som vid 
minst ett tillfälle hade besökt någon av de 14 inkluderade vårdcentralerna och fått 
astmaläkemedel förskrivet inkluderades. Barnen skulle ha initierats på astmabehandling 
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mellan juli 2006 och juni 2007 och följdes sedan avseende ytterligare utköp under 24 
månader via Läkemedelsregistret. Barnen (totalt 1033 barn) delades in i två åldersgrupper, 
förskolebarn (0-6 år) och skolbarn (i denna studie 7-16 år) beroende på olika 
behandlingsrekommendationer för dessa åldersgrupper. De huvudsakliga utfallsmåtten var: 
vilken vårdnivå som initierade behandlingen, i vilken utsträckning barnen köpte ut läkemedel 
i enlighet med behandlingsrekommendationerna samt antal utköp av respektive 
astmaläkemedel under observationsperioden. 
Resultat: Astmabehandling initierades inom primärvården hos 42 % av förskolebarnen 
respektive hos 72 % av skolbarnen. Den vanligaste läkemedelsbehandlingen som användes 
vid initieringen av astmabehandlingen hos förskolebarn var symtomlindrande läkemedel 
kombinerat med förebyggande anti-inflammatoriskt läkemedel. Detta köptes ut av 64 % av 
förskolebarnen. Av skolbarnen köpte 50 % enbart ut symtomlindrande läkemedel vid 
initieringen av astmabehandlingen. De flesta barnen, 35 %  av förskolebarnen och 54 % av 
skolbarnen gjorde bara ett utköp av astmaläkemedel under observationsperioden. 
Studie II: Evidence-based management of childhood asthma in Swedish primary care – 
a controlled educational intervention study 
Syfte: Att undersöka om distriktsläkares följsamhet till de evidensbaserade  
behandlingsriktlinjerna kan förbättras genom en utbildningsintervention 
Metod: En kontrollerad interventionsstudie. Distriktsläkare och sjuksköterskor vid de 14 
vårdcentralerna i studie I deltog i interaktiva utbildningsseminarier avseende evidensbaserat 
omhändertagande av barn med astma. 14 andra vårdcentraler, matchade till storlek, ägarform 
och socioekonomiska faktorer utgjorde kontrollgrupp. Data avseende läkemedelsutköp samt 
diagnos inhämtades via register (Läkemedelsregistret samt gemensamma vårdregistret 
GVR/VAL) under en 24-månaders period före respektive efter interventionen. Alla barn 0-17 
år listade på de 28 vårdcentralerna någon gång under perioden 2006-2012 inkluderades (totalt 
114 175 barn). Ur denna kohort studerades först utköpsmönstret av astmaläkemedel hos barn 
med diagnosen astma. Därefter beräknades andelen barn med diagnosen astma av alla barn 
som köpt ut astmaläkemedel. Barnen delades in i två åldersgrupper, förskolebarn (0-6 år) 
respektive skolbarn (7-17 år). 
Resultat:  I den första delen av studien såg vi att barn med astmadiagnos i båda 
åldersgrupperna köpte ut astmaläkemedel enligt behandlingsriktlinjerna såväl före som efter 
interventionen. Det förelåg ingen statistisk skillnad mellan interventions- och kontrollgrupp 
före eller efter interventionen. Vid en sammanslagning av interventions- och 
kontrollgrupperna fann vi att 73 % av förskolebarnen respektive 72 % av skolbarnen köpte ut 
både symtomlindrande och anti-inflammatoriskt astmaläkemedel efter interventionen. 
Liknande siffror sågs före interventionen. I den andra delen av studien såg vi att av alla barn i 
hela kohorten som köpt ut astmaläkemedel utgjorde andelen barn med astmadiagnos hos 
förskolebarnen 80 % i interventionsgruppen respektive 75% i kontrollgruppen. Hos 
skolbarnen var siffran 70 % i interventionsgruppen respektive 64 % i kontrollgruppen. En 
statistisk säkerställd skillnad (p<0.001) mellan interventions- och kontrollgrupp förelåg i båda 
åldersgrupperna såväl före som efter interventionen. Eftersom interventions- och 
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kontrollgruppen inte var jämförbara före interventionen kunde någon utvärdering av 
interventionen inte göras i denna del av studien. 
Studie III: Practice guidelines in the context of primary care, learning and usability in 
the physicians´ decision-making process – a qualitative study  
Syfte: Att utforska distriktsläkares attityd till behandlingsriktlinjer samt hur de lär sig av och 
använder behandlingsriktlinjer i den dagliga beslutsprocessen på en vårdcentral. 
Metod: En kvalitativ studie där fokusgruppsintervjuer användes som metod för att utforska 
hur distriktsläkare använder behandlingsriktlinjerna i sin beslutsprocess, faktorer som 
påverkar besluten, hur de närmar sig/deras attityder till riktlinjerna samt hur riktlinjerna kan 
uppmuntra till en lärandeprocess i det kliniska rutinarbetet. Totalt deltog 22 distriktsläkare 
med i genomsnitt sju års erfarenhet av primärvårdsarbete. Distriktsläkarna kom från sju av de 
inkluderade vårdcentralerna. Intervjuerna transkriberades ordagrant och en kvalitativ 
innehållsanalys av materialet genomfördes. 
Resultat: Tre teman med underliggande kategorier kunde utkristalliseras: 1. Lärande från 
riktlinjer i form av interaktiva kontextualiserade dialoger. Detta tema understöddes av 
följande kategorier: a. Återkoppling genom diskussion med kollegor (på vårdcentralen) b. 
Återkoppling genom samarbete med andra specialister. 2. Lärande som etablerar ett 
förtroende och en tilltro till att förmedla vård av hög kvalitet. Detta tema understöddes av 
följande kategorier: a. Förtroende genom bekräftelse b. Förtroende genom pålitlighet. c. 
Förtroende genom utvärdering av egna resultat.  3. Lärande genom att använda relevant 
vetenskapligt underlag i beslutsprocessen. Detta tema understöddes av följande kategorier: a. 
Design och lay-out som åskådliggör evidens/ information. b. Tillgänglighet anpassad till den 
kliniska beslutsprocessen som ett krav för användning av riktlinjerna. 
Studie IV: Influence of contextual circumstances on quality of primary care in children 
with asthma 
Syfte: Att utvärdera om kontextuella faktorer/funktioner har något inflytande på 
vårdcentralernas följsamhet till behandlingsriktlinjerna för handläggningen av barn med 
astma inom primärvården. 
Metod: En tvärsnittsstudie som utfördes på de 14 vårdcentralerna i studie I. Kontextuella 
faktorer/funktioner inkluderade: 1. Socio-demografiska karakteristika 2. Organisatoriska 
karakteristika. 3. Indikatorer på engagemang inom astmavård. Data avseende kontextuella 
faktorer/funktioner insamlades via checklistor, enkäter samt via personlig kontakt med 
verksamhetschefen. Aktivitetsgrad på utbildningsseminarierna i studie II utgjorde ett mått på 
engagemang. Vårdkvalitet bedömdes genom att först granska journaler på vårdcentralerna 
avseende dokumentation av definierade kvalitetsindikatorer. Därefter gjordes en 
sammanslagning av kvalitetsindikatorerna till ett kvalitets-index, ”composite quality 
indicator” (CQI) för varje vårdcentral. Genom att utföra en multivariat regressionsanalys, 
”orthogonal projection to latent structures” (OPLS) kunde en relation mellan CQI och de 
kontextuella fakorerna/funktionerna beräknas. 
Resultat: Med hjälp av OPLS-analysen kunde tio kontextuella faktorer/funktioner med 
inflytande på CQI identifieras.  En lägre åldersgräns för att utföra spirometri, mer schemalagd 
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tid för astmavård, lägre tjänstgöringsgrad för distriktsläkare samt en högre aktivitetsgrad på 
utbildningsseminarierna var de kontextuella faktorerna/funktionerna med störst inflytande på 
CQI. 
Slutsats av de fyra studierna 
Evidensbaserade behandlingsriktlinjer är diagnosbaserade och distriktsläkare har god 
följsamhet till behandlingsriktlinjerna avseende läkemedelsbehandling om barnen har en 
astmadiagnos. I studie I förutsatte vi att barnen som köpte ut astmaläkemedel också hade en 
astmadiagnos. Vår slutsats efter studie I och II var dock att symtomlindrande 
läkemedelsbehandling för astma, framför allt hos skolbarn, delvis används i diagnostiskt 
syfte. En ökad diagnostik av astma bör därför eftersträvas hos skolbarn innan 
läkemedelsbehandling inleds. En ökad användning av lungfunktionsmätning i form av 
spirometri kan vara ett sätt att uppnå detta. Eftersom läkemedelsbehandlingen visade en god 
överensstämmelse med behandlingsriktlinjerna redan före interventionen kunde ingen 
utvärdering av interventionens effekt göras. För att vara ett stöd i den dagliga 
beslutsprocessen bör behandlingsriktlinjerna vara lättillgängliga, koncisa och inge förtroende. 
Kontextualiserade dialoger baserade på distriktsläkarnas egna erfarenheter är viktiga liksom, 
återkoppling på egna resultat. Slutligen kan en evidensbaserad vård av barn med astma 
underlättas av: särskilt avsatt tid, en förbättrad interprofessionell samverkan och en struktur 
på vårdcentralerna som ger möjlighet för engagemang i astmavård.        
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Appendix 1 
The following case exemplifies how the decision making process could be discussed 
during a seminar. 
Dr Lena Karlsson is a general practitioner at Valbo Primary Health Care Centre. Dr Karlsson 
has as usual a fully booked day and the last patient before lunch is Erik, a 15-year old boy 
who comes with his mother who is worried about her son´s long-time coughing. Erik and his 
mother meet Dr Karlsson for the first time and just before the appointment the nurse Katarina 
Pettersson, who has performed a spirometry, mentions that Erik smells like he has been 
smoking. 
Background: Valbo Primary Health Care Centre is located in a district with many small 
children as well as many elderly people requiring a high need of care. Seven general 
practitioners work at the centre but one position has been vacant since several months. Also 
based at the centre are six highly competent nurses and a small laboratory. One half-day a 
month is scheduled for continuing medical education activities together with surrounding 
primary health care centres. Up-dated regional guidelines are available at a local website. 
Cooperation with the local paediatric outpatient clinic is rare, apart from phone-calls. Because 
of a vacancy at the paediatric outpatient clinic there is a couple of months waiting time for an 
appointment when a patient is referred.  
Dr Lena Karlsson has been working six years at Valbo Primary Health care Centre. She has 
a special interest in patients with asthma and has recently established team-based care with 
Katarina Pettersson, the nurse responsible for asthma care. They are responsible for the 
asthma team at Valbo and Dr Karlsson has the main responsibility to see that Valbo fulfils the 
criteria to offer a good asthma care. As a result of the vacancy and various reorganisations Dr 
Karlsson has not had any time for education, reading or reflection during the past months. 
Erik has chronic asthma and allergy towards cat and birch pollen. He has regular treatment 
with inhaled steroids and inhaled beta2- agonist when needed since many years. The 
treatment was initiated at the local paediatric outpatient clinic. Three years ago Erik was 
referred to primary care. At the last visit 5 months ago he was feeling well and his asthma was 
considered stable. 
Erik’s´ parents are divorced and have divided custody. His mother works part-time as a 
secretary. She smokes but only outdoors. Eriks´s father runs a painting company and works a 
lot. He has asthma since childhood. 
Erik is an average student. He spends most of his time playing with his band or being with his 
girlfriend who has a cat.  
The spirometry shows a low FEV1.0 of 82 % and a significant reversibility of 15 %. When 
inhaling his beta-2 stimulator nurse Katarina Pettersson notices insufficient technique. When 
she corrects Erik his mother gets upset since no one has shown the inhalation technique 
before. Erik remembered that he should have been shown the technique a couple of years ago 
but that his father found that unnecessary since he was taken the same type of medicine 
himself... 
Specific problem: What decision would you make if you stood in the position of Dr 
Karlsson? 
Examples of factors and aspects in the decision making process to discuss during a 
seminar 
What: Can the participants identify the problem in the case? What are the 
possibilities/difficulties in following the guidelines in a case like this? 
Context: Social setting of Valbo Primary Health Care Centre and the surrounding health care 
organisation. Dr  Karlsson´s workload. Erik´s current lifestyle, medical history and family 
situation. 
Content: Dr  Karlsson´s, Erik´s and his parents knowledge, attitudes, motivation and ability 
to communicate. 
Cost: Dr Lena Karlsson´s and nurse Katarina Petterson´s increased time commitment required 
to motivate and explain to Erik and his parents. Financial commitment for the parents. 
Ethics:  The priority of this patient compared to other patients at Valbo Primary Health Care 
Centre. 
Who:  Does Dr Karlsson have the responsibility to make a decision? Are the guidelines 
applicable to Erik? 
Sense of coherence:  Dr Lena Karlsson´s and nurse Katarina Petterson´s sense of professional 
coherence. Erik’s sense of coherence as a patient. His mother´s and father´s coherence as 
parents to a teenager with a chronic disease. 
How: Can Dr Lena Karlsson and nurse Katarina Pettersson interact and benefit from the 
specific knowledge in their professions in the motivational work with Erik and his parents? 
When:  Urgency, importance and timing in the life of Erik and his parents and in the schedule 
of Dr Lena Karlsson and nurse Katarina Pettersson.  
Dr Karlsson´s task: To schedule a treatment and motivational plan together with nurse 
Katarina Pettersson for Erik and his parents or to refer him to the local paediatric outpatient 
clinic. To preserve or continue to develop the asthma team at Valbo Primary Health Care 
Centre.   
 
Appendix 2 
Interview guide (translated from Swedish) 
 
Opening question 
1. Please tell us your name and if you are a general practitioner or a resident. 
The purpose with this question is to give everyone a possibility to speak 
Core questions 
1. How do you act when you decide how to take care of your patient? How do you 
use guidelines in your decision-making? 
- Guidelines as a dictionary or as confirmation of own knowledge (probe question) 
- When you have a patient, do you use one kind of guidelines only or do you compare 
several   different kinds? (probe question) 
- Do you use the guidelines before, after or during the patient-visit? (probe question) 
2. Please give example of factors that influence your decision to approach a specific 
type of guideline? 
- How does the design and lay-out affect your choice of guideline? (probe question) 
- How does the amount of time you have affect your choice of guideline (probe 
question) 
3. What is your opinion of the fact that there are guidelines for most diseases that 
you handle and that you are expected to follow them in your daily practice? 
- Do you see the guidelines mostly as a support or as an obstacle in your daily 
practice? (probe question) 
- In what way may the guidelines support your decision-making? (probe question) 
- In what way may the guidelines hinder you in your decision-making? (probe 
question) 
Closing questions 
1. If you were asked to advice the authors of the guidelines, what advice(s) would you 
give? 
2. If you were asked to advice your junior colleagues in the use of guidelines in daily 
practice, what advice(s) would you give? 
 
 
 
Appendix 3 
Checklist for primary health care centre (translated from Swedish) 
Primary health care centre (name):______________________________ 
Aspect
1 
Yes No Comments 
Organisation    
Is there scheduled time for astma 
care? 
  Hours/week: 
Is there an asthma nurse?    
Is there a nurse with further education 
in asthma and allergy? 
  If yes, how many? 
Is there a GP with responsibility for 
asthma? 
   
Is there a GP with further education in 
asthma and allergy? 
  If yes, how many? 
Equipment    
Is there a spirometer?    
Is it used in children with asthma?   If yes, how often? 
Always □  Often□  Rarely□ 
If yes, from which age?   Age: 
Is there a PEF-meter?    
Is it used in children?   If yes, how often? 
Always □  Often□  Rarely□ 
Demonstration and patient 
education 
   
Are there inhaler devices for 
demonstration? 
   
Is there patient education material?    
If yes, is it distributed?   Always□  Often□   Rarely□ 
Is there material regarding smoking 
cessation? 
   
If yes, is it distributed?   Always□  Often□   Rarely□ 
Is there a checklist or other structured 
information used when educating 
children with asthma? 
   
1
Aspects from the original checklist relevant for this study 
Comments: 
 
